Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cardiac Hypertrophic Response WP2795,0.001851018327923273,2.5728349504541703,16.188327276679026,"['MAP2K3', 'HDAC4', 'MAP2K1', 'MAP3K1', 'CHUK', 'PDPK1', 'MAPK14', 'HDAC9', 'TGFBR1', 'HDAC7', 'MAPK8', 'AKT2', 'PRKD1', 'RAF1', 'MAP3K7', 'MAP3K14', 'MAP2K5', 'FGFR2', 'MAPK3']",0.40976208586466106,0,0,19
2,Sulindac Metabolic Pathway WP2542,0.0019190574533574885,inf,inf,"['MSRA', 'MSRB2', 'CYP1B1', 'MSRB3']",0.40976208586466106,0,0,4
3,Mesodermal commitment pathway WP2857,0.0022555711148513455,1.9279034690799397,11.749322501566132,"['SETD2', 'CTBP2', 'NCAPG2', 'HTT', 'PHF6', 'MBTD1', 'PPP2CA', 'EPB41L5', 'C1QBP', 'UBR5', 'CEP250', 'DIP2A', 'PRKACA', 'KDM6A', 'ACVR1', 'SMAD2', 'ATP8B2', 'TET1', 'AXIN2', 'ELP4', 'TRERF1', 'EMSY', 'EXT1', 'LATS1', 'EXT2', 'MEIS1', 'KLF5', 'BHLHE40', 'TCF4', 'WDFY2', 'BMPR1A', 'NFE2L2', 'CUL4B']",0.40976208586466106,0,0,33
4,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.00415807012134172,2.477770063871147,13.584880398976406,"['EIF4A2', 'MAP2K3', 'MAP2K1', 'RPS6', 'MAPK14', 'RPTOR', 'MAPK10', 'MAPK9', 'MAPK8', 'RPS6KA5', 'AKT2', 'PDCD4', 'PRKACA', 'EIF4E', 'MAP2K5', 'MAPK3', 'EIF4G1']",0.4205527557273762,0,0,17
5,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.004269878545749218,2.79112494543246,15.228851902586149,"['MAP2K3', 'MAP2K1', 'JUN', 'MAP3K1', 'MAPK14', 'MAPK10', 'RPS6KA3', 'MAPK9', 'MAPK8', 'MAP3K9', 'RAF1', 'EIF4E', 'MAP3K4', 'MAPK3']",0.4205527557273762,0,0,14
6,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.004956101570798468,1.7523697676369432,9.300064365312513,"['PRKAA1', 'THRB', 'IRS1', 'MAPKAP1', 'PIK3R4', 'CBLB', 'CBL', 'RPTOR', 'RPS6KA3', 'GYS1', 'MAPK9', 'RPS6KA6', 'MAPK8', 'RPS6KA5', 'SESN3', 'AKT2', 'MAP3K9', 'MAP4K5', 'MAP3K7', 'EIF4E', 'MAP3K4', 'MAP2K5', 'MAPK3', 'MAP4K4', 'MAP2K3', 'MAP3K3', 'MAP2K1', 'MAP3K1', 'PDPK1', 'INSR', 'MAPK14', 'MAPK10', 'MLXIPL', 'RAF1', 'MAP3K13', 'MAP3K14']",0.4205527557273762,0,0,36
7,Insulin Signaling WP481,0.00540159502769107,1.638838254951999,8.556474487631895,"['PRKAA1', 'STXBP3', 'IRS1', 'STXBP4', 'INPPL1', 'PIK3R4', 'CBLB', 'CBL', 'GYS2', 'CYTH3', 'RPS6KA3', 'GYS1', 'MAPK9', 'RPS6KA6', 'MAPK8', 'RPS6KA5', 'AKT2', 'MAP3K9', 'MAP4K5', 'MAP3K7', 'EIF4E', 'MAP3K4', 'MAP2K5', 'MAPK3', 'MAP4K4', 'MAP2K3', 'MAP3K3', 'MAP2K1', 'RAB4A', 'JUN', 'MAP3K1', 'PDPK1', 'INSR', 'SORBS1', 'MAPK14', 'INPP4A', 'MAPK10', 'RHOJ', 'RAF1', 'MAP3K13', 'SGK1', 'MAP3K14', 'PFKM', 'ARF6']",0.4205527557273762,0,0,44
8,MAPK Signaling Pathway WP382,0.007360784442571838,1.509830654606553,7.415667287842216,"['LRRK2', 'ARRB1', 'FGF5', 'RPS6KA3', 'PPP3CB', 'RPS6KA5', 'PPP3CC', 'FGF9', 'AKT2', 'PRKACA', 'MAP3K7', 'MAP3K4', 'MAP2K3', 'DAXX', 'MAP2K1', 'DUSP3', 'CHUK', 'RRAS2', 'DUSP6', 'TGFBR1', 'MAPK8IP1', 'CDC25B', 'CACNB2', 'CACNB4', 'RASA1', 'RASA2', 'RAF1', 'CACNA1B', 'CACNA1A', 'RAP1B', 'MAPK9', 'CACNG8', 'MAPK8', 'FLNB', 'CACNG2', 'PAK2', 'MAP2K5', 'MAP4K4', 'MAPK3', 'NTRK2', 'JUN', 'JUND', 'MAP3K1', 'GADD45A', 'NFATC3', 'HSPA2', 'MAPK14', 'MAPK10', 'TAOK1', 'NF1', 'TAB2', 'KRAS', 'MAP3K13', 'LAMTOR3', 'MAP3K14', 'FGFR2']",0.5014534401502064,0,0,56
9,Proteoglycan biosynthesis WP4784,0.009297085991479404,3.7837351565311264,17.700518375940042,"['EXT1', 'EXT2', 'CHSY1', 'B3GAT3', 'IMPAD1', 'XYLT1', 'B3GALT6', 'EXTL3']",0.5469832406247045,0,0,8
10,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.013322293507935245,2.164252203949064,9.345925880003158,"['MAP2K3', 'MAP3K3', 'MAP2K1', 'MAP3K1', 'CHUK', 'MAPK14', 'MAPK10', 'MAPK9', 'MAPK8', 'RPS6KA5', 'IRAK2', 'TAB2', 'MAP3K7', 'EIF4E', 'MAP3K14', 'MAPK3']",0.5469832406247045,0,0,16
11,TNF-alpha signaling pathway WP231,0.014226155516099242,1.7880808274015274,7.60412318329845,"['PPP2CA', 'MAPK9', 'MAPK8', 'TBK1', 'PSMD2', 'RFK', 'BTRC', 'RFFL', 'MAP3K7', 'GLUL', 'MAPK3', 'MAP2K3', 'MAP3K3', 'HSP90AA1', 'JUN', 'MAP3K1', 'CHUK', 'BAD', 'KSR2', 'MADD', 'KRAS', 'TAB2', 'RAF1', 'MAP3K14', 'NSMAF']",0.5469832406247045,0,0,25
12,Glycolysis in senescence WP5049,0.014595335743534376,4.538511326860841,19.18452914936029,"['RB1', 'LDHA', 'PRKAA1', 'PKM', 'ENO1', 'GAPDH']",0.5469832406247045,0,0,6
13,Pathogenic Escherichia coli infection WP2272,0.015346636469407312,2.1846903096903096,9.125143276228384,"['ITGB1', 'ROCK1', 'TUBB', 'ARPC1A', 'TUBB4B', 'TUBB4A', 'ACTB', 'TUBA4A', 'TUBA1B', 'CTTN', 'ARPC2', 'ABL1', 'FYN', 'EZR', 'NCK1']",0.5469832406247045,0,0,15
14,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.015429259982598708,1.567281382953485,6.5378979475858126,"['SHC4', 'GRIA1', 'PRKAA1', 'DOCK3', 'IRS1', 'PPP2CA', 'RPS6KA3', 'MAPK9', 'MAPK8', 'RPS6KA5', 'FYN', 'EIF4E', 'MAP2K5', 'GRIA3', 'NCK1', 'MAPK3', 'NSF', 'NTRK2', 'MAP2K1', 'JUN', 'CDKL5', 'MAP3K1', 'CHUK', 'PDPK1', 'KIDINS220', 'SORT1', 'BAD', 'NTRK3', 'RPS6', 'EEF2', 'MAPK14', 'VAV2', 'MAPK10', 'TIAM1', 'DLG1', 'CDK5', 'RAF1', 'CDK5R1']",0.5469832406247045,0,0,38
15,Hippo-Merlin Signaling Dysregulation WP4541,0.01677627495827889,1.754800600745568,7.1732556379721935,"['ITGB1', 'FLT3', 'CDH8', 'CDH6', 'DCAF1', 'PPP1CC', 'CDH20', 'PRKAR2B', 'PRKAR2A', 'ITGB8', 'PAK6', 'PRKACA', 'PAK2', 'PDGFRA', 'NTRK2', 'INSR', 'LATS1', 'DDB1', 'CUL4A', 'LIN28B', 'CDH10', 'CDH12', 'KRAS', 'FGFR2', 'VGLL4']",0.5469832406247045,0,0,25
16,Pathways affected in adenoid cystic carcinoma WP3651,0.019028926183702204,1.9479337563844605,7.717314268613483,"['MAGI1', 'SETD2', 'CNTN6', 'KMT2C', 'MGA', 'ARID4B', 'SMARCA2', 'MORF4L1', 'KANSL1', 'KAT6A', 'NSD1', 'EP300', 'TLK1', 'ATM', 'MAML3', 'RAF1', 'CMTR2', 'KDM6A']",0.5469832406247045,0,0,18
17,Insulin signaling in adipocytes (diabetic condition) WP3635,0.019992241799129545,7.560905497664391,29.581369768919675,"['IRS1', 'INSR', 'AKT2', 'RPS6']",0.5469832406247045,0,0,4
18,Insulin signaling in adipocytes (normal condition) WP3634,0.019992241799129545,7.560905497664391,29.581369768919675,"['IRS1', 'INSR', 'AKT2', 'RPS6']",0.5469832406247045,0,0,4
19,Endoderm differentiation WP2853,0.020411631565846407,1.6249028447069795,6.3235537500315,"['CTBP2', 'NCAPG2', 'PHF6', 'CDC73', 'MBTD1', 'EPB41L5', 'CAND1', 'C1QBP', 'UBR5', 'CEP250', 'DIP2A', 'BPTF', 'MAP2K3', 'SMAD2', 'ATP8B2', 'SFMBT1', 'TET1', 'CDYL', 'FOXN3', 'ELP4', 'TRERF1', 'EMSY', 'EXT1', 'MAD2L2', 'TNRC6C', 'TCF4', 'WDFY2', 'EZH2', 'BMPR1A', 'CUL4B']",0.5469832406247045,0,0,30
20,Autophagy WP4923,0.02059512331649793,2.4488472622478388,9.508141624400396,"['RPTOR', 'BECN1', 'PRKAA1', 'MAP1LC3B', 'ATG9A', 'AKT1S1', 'PIK3R4', 'AMBRA1', 'ATG7', 'ATG13', 'ATG5']",0.5469832406247045,0,0,11
21,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.021220561292936223,3.0264123785534367,11.660115292904072,"['NQO2', 'JUN', 'MAPK8', 'SRXN1', 'GSTP1', 'KEAP1', 'MAPK14', 'NFE2L2']",0.5469832406247045,0,0,8
22,Neuroinflammation WP4919,0.023697233627022068,4.72636592379583,17.687937475705464,"['JUN', 'MAPK8', 'CHUK', 'ASCC1', 'MAPK14']",0.5469832406247045,0,0,5
23,Thiamine metabolic pathways WP4297,0.023697233627022068,4.72636592379583,17.687937475705464,"['BCKDHA', 'PDHA1', 'TPK1', 'SLC19A3', 'SLC19A2']",0.5469832406247045,0,0,5
24,Canonical and non-canonical TGF-B signaling WP3874,0.024087335366959464,3.78173318950018,14.09099910642015,"['SMAD2', 'MAPK9', 'MAPK8', 'MAPK14', 'TGFBR1', 'BMPR1A']",0.5469832406247045,0,0,6
25,Histone Modifications WP2369,0.02799637275674216,2.0383089683486366,7.288341267466239,"['KMT2E', 'SETD2', 'KMT2A', 'KMT2C', 'SETD7', 'DOT1L', 'SETDB2', 'EHMT1', 'ASH1L', 'SETBP1', 'NSD1', 'SMYD2', 'HIST1H4C', 'EZH2']",0.5868470443240184,0,0,14
26,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.02799637275674216,2.0383089683486366,7.288341267466239,"['BECN1', 'PRKAA1', 'PIK3R4', 'PLA2G6', 'GTPBP2', 'ATG13', 'RPTOR', 'DCAF17', 'SCP2', 'AKT1S1', 'ATG4A', 'ATG7', 'ATG5', 'FTL']",0.5868470443240184,0,0,14
27,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.030052915455952626,2.1625740025740026,7.579379854393577,"['ITGB1', 'LATS1', 'MAPK10', 'MAPK9', 'MAPK8', 'SGMS1', 'ITGB8', 'PAK6', 'MAP4K5', 'PAK2', 'ACTB', 'MAP4K4']",0.6066236638331178,0,0,12
28,Glycolysis and Gluconeogenesis WP534,0.034854649218952996,2.1906567571666917,7.353090000165504,"['LDHB', 'LDHA', 'PDHA1', 'PKM', 'PGAM1', 'GOT2', 'ENO1', 'ENO2', 'DLD', 'PFKM', 'GAPDH']",0.6497173576759842,0,0,11
29,MAPK Cascade WP422,0.034854649218952996,2.1906567571666917,7.353090000165504,"['MAP2K3', 'MAPK10', 'MAP3K3', 'MAP2K1', 'JUN', 'MAP3K1', 'KRAS', 'MAPK14', 'RAF1', 'LAMTOR3', 'MAPK3']",0.6497173576759842,0,0,11
30,Signal transduction through IL1R WP4496,0.035843161021439356,2.431888306078371,8.094789487117815,"['MAP2K3', 'MAPK8', 'JUN', 'MAP3K1', 'CHUK', 'IRAK2', 'MAPK14', 'MAP3K7', 'MAP3K14']",0.6497173576759842,0,0,9
31,BMP Signaling Pathway in Eyelid Development WP3927,0.03695640016138625,3.241177377099707,10.689456259018359,"['MAPK9', 'JUN', 'MAP3K1', 'SMAD5', 'FGFR2', 'MAPK3']",0.6497173576759842,0,0,6
32,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.039345539070149115,3.780733285406183,12.232081166769957,"['GRM3', 'GRM2', 'GRM5', 'GRM4', 'GRM7']",0.6538658242912636,0,0,5
33,16p11.2 proximal deletion syndrome WP4949,0.040289977875088534,1.683010079106935,5.405243576762549,"['UNC13B', 'MAP2K3', 'CCT2', 'PAXIP1', 'KMT2C', 'PPP4R3A', 'PPP2R5D', 'PPP2CA', 'CCT6A', 'PPP4R1', 'PPP2R1A', 'ASPHD1', 'PPP4R4', 'TCP1', 'CCT8', 'EZR', 'CCT5', 'YPEL3', 'MAPK3', 'BPTF']",0.6538658242912636,0,0,20
34,Circadian rhythm related genes WP3594,0.04079162940532653,1.4174851749912394,4.534929674681025,"['KDM5A', 'DDX5', 'NLGN1', 'PRKAA1', 'PHLPP1', 'AHCY', 'CHRM1', 'KMT2A', 'CIPC', 'BHLHE41', 'RBM4B', 'RORA', 'CCAR2', 'ARNTL2', 'NPAS2', 'ARNTL', 'PPP1CC', 'MAPK9', 'MAPK8', 'EP300', 'PRKG2', 'BTRC', 'JUN', 'JUND', 'KCNH7', 'NTRK3', 'GFPT1', 'ARNT', 'BTBD9', 'NR2F6', 'SETX', 'PER2', 'MAPK10', 'STAR', 'MYBBP1A', 'PSPC1', 'BHLHE40', 'TOP1', 'LGR4', 'EZH2']",0.6538658242912636,0,0,40
35,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.04215277611911792,1.8923548503425893,5.992055973997663,"['SMAD2', 'JUN', 'ZFYVE9', 'LTBP3', 'SMAD5', 'TGFBR1', 'ADAMTS10', 'MAPK9', 'ZEB2', 'EP300', 'ZNF423', 'JAK1', 'MAPK3', 'FBN1']",0.6563789424262647,0,0,14
36,EGF/EGFR signaling pathway WP437,0.044948069021202755,1.4042254850409202,4.356254968611003,"['ATF1', 'ROCK1', 'SH3KBP1', 'INPPL1', 'CBLB', 'ASAP1', 'IQGAP1', 'CBL', 'PIK3C2B', 'RPS6KA3', 'MAPK9', 'GJA1', 'MAPK8', 'RPS6KA5', 'ABL1', 'MAP3K4', 'SH3GL2', 'MAP2K5', 'NCK1', 'JAK1', 'MAP3K3', 'MAP2K1', 'JUN', 'JUND', 'MAP3K1', 'PDPK1', 'TNK2', 'NCOA3', 'STAM', 'EPS15L1', 'GAB2', 'AP2B1', 'MAPK14', 'EPN1', 'VAV2', 'RASA1', 'KRAS', 'RAF1', 'STAM2', 'ARF6']",0.6804638226820973,0,0,40
37,Aryl Hydrocarbon Receptor Pathway WP2873,0.047001123793864535,2.269546436285097,6.939328342151885,"['HSP90AA1', 'JUN', 'JUND', 'AIP', 'EP300', 'CYP1B1', 'ARNT', 'POLK', 'NFE2L2']",0.6923138504771938,0,0,9
38,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.05149343635685502,2.101588444764534,6.233943755694567,"['HDAC4', 'PPP3CB', 'PPP3CC', 'NFATC3', 'EP300', 'NELFB', 'HDAC8', 'SUPT5H', 'HDAC9', 'HDAC7']",0.7385242845917366,0,0,10
39,Ectoderm Differentiation WP2858,0.05444798936780103,1.4571301023966965,4.240990796657765,"['NLGN1', 'STX16', 'CTNND2', 'ARHGDIG', 'LDB2', 'JAKMIP1', 'CELSR2', 'CDH8', 'ZBTB2', 'PHF8', 'CDH6', 'TRPM2', 'PLXNA2', 'DMD', 'FYN', 'CTNNA2', 'CLVS1', 'TTC14', 'BCAS3', 'KCNK10', 'SMURF1', 'GREB1', 'C1GALT1', 'SORCS1', 'PPFIBP2', 'ROR2', 'FGFR2', 'TRIM33', 'ASTN1', 'BMPR1A']",0.7532621228742763,0,0,30
40,Computational Model of Aerobic Glycolysis WP4629,0.05997073185946414,3.1503115264797508,8.8646573140043,"['LDHA', 'PKM', 'ENO1', 'GAPDH', 'PFKM']",0.7532621228742763,0,0,5
41,Interferon type I signaling pathways WP585,0.06072350824764519,1.7658612814040149,4.946926827939992,"['MAP2K3', 'MAP3K1', 'IRS1', 'MAPKAP1', 'RPS6', 'GAB2', 'CBL', 'MAPK14', 'RPTOR', 'RPS6KA5', 'PDCD4', 'FYN', 'EIF4E', 'JAK1']",0.7532621228742763,0,0,14
42,Synaptic Vesicle Pathway WP2267,0.06072350824764519,1.7658612814040149,4.946926827939992,"['UNC13B', 'NSF', 'SYT1', 'CLTC', 'CACNA1B', 'CACNA1A', 'AP2B1', 'SYN3', 'SYN2', 'DNM2', 'DNM3', 'RIMS1', 'SLC17A7', 'STX2']",0.7532621228742763,0,0,14
43,Senescence and Autophagy in Cancer WP615,0.06101804373599597,1.5425490590047553,4.313870577639021,"['RB1', 'MAP2K3', 'BECN1', 'MAP2K1', 'JUN', 'GSN', 'KMT2A', 'CDKN2A', 'HMGA1', 'AMBRA1', 'BMI1', 'MAPK14', 'ATG13', 'CDC25B', 'RSL1D1', 'MAP1LC3B', 'LAMP1', 'AKT1S1', 'RAF1', 'SLC39A1', 'ATG7', 'ATG5']",0.7532621228742763,0,0,22
44,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.0620240391111327,1.577370196361884,4.3854570540531155,"['MAP2K3', 'HDAC4', 'MAP2K1', 'CHUK', 'ROCK1', 'PDPK1', 'MAPK14', 'HDAC9', 'AGT', 'HDAC7', 'LRP6', 'PPP3CB', 'MAPK8', 'AKT2', 'DVL1', 'RAF1', 'MAP3K14', 'MAP2K5', 'FGFR2', 'MAPK3']",0.7532621228742763,0,0,20
45,3q29 copy number variation syndrome WP4906,0.06219595509971089,1.6820241388989134,4.671763699574998,"['DYNC2H1', 'GRIA1', 'JUN', 'PCYT1A', 'DYNLT1', 'MYCBP2', 'ADAM10', 'MAD2L1BP', 'PIGX', 'RNF168', 'DLG1', 'BRINP1', 'WDR60', 'FGFR1OP', 'DYNLRB1', 'PAK2']",0.7532621228742763,0,0,16
46,DNA damage response (only ATM dependent) WP710,0.06722293681881547,1.4897563233121518,4.021955880404004,"['JUN', 'MAP3K1', 'IRS1', 'CDKN2A', 'BAD', 'INSR', 'PIK3R4', 'PPP2R5C', 'SOD2', 'PIK3C2B', 'MAPK10', 'MAPK9', 'MAPK8', 'SCP2', 'AKT2', 'CCNG2', 'DVL1', 'ABL1', 'ATM', 'KRAS', 'MAP3K7', 'WNT2', 'LDLR', 'MAP3K4']",0.796445664483792,0,0,24
47,Exercise-induced Circadian Regulation WP410,0.07180129210581904,1.7087351534962716,4.500556880775453,"['IDI1', 'GSTM3', 'BTG1', 'GSTP1', 'GFRA1', 'QKI', 'ARNTL', 'HERPUD1', 'ETV6', 'PER2', 'VAPA', 'SUMO3', 'TAB2', 'ERC2']",0.8083151240943924,0,0,14
48,Regulatory circuits of the STAT3 signaling pathway WP4538,0.07243119661838358,1.6364079705833585,4.2957643132770755,"['PTPRT', 'PDGFRA', 'MAPKAP1', 'SETD7', 'LIFR', 'IFNLR1', 'MAPK14', 'RPTOR', 'PTPRD', 'MAPK10', 'MAPK9', 'MAPK8', 'AKT1S1', 'JAK1', 'MAPK3', 'IL12RB2']",0.8083151240943924,0,0,16
49,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.07384061711927983,2.520436293899077,6.567869669738386,"['MAP2K3', 'PRKAA1', 'MAP2K1', 'RAF1', 'EIF4E', 'MAPK3']",0.8083151240943924,0,0,6
50,CAMKK2  Pathway WP4874,0.07910609175425128,1.8910694994598487,4.797577877486975,"['HDAC4', 'RPTOR', 'CHRM3', 'STIM1', 'EP300', 'NOS1', 'ARHGEF7', 'RAF1', 'MAPK3', 'NFE2L2']",0.8083151240943924,0,0,10
51,Fragile X Syndrome  WP4549,0.08009141688839115,1.381277213352685,3.487153923826169,"['GRIA1', 'ABCD3', 'CLTC', 'ITPR1', 'GPHN', 'RPTOR', 'GRIN2A', 'GRM5', 'FYN', 'PRKACA', 'EIF4E', 'GABRD', 'SH3GL1', 'EPHA4', 'GABRA1', 'NTRK2', 'MAP2K1', 'DUSP3', 'CDKN2A', 'AP2B1', 'DNM2', 'ALDH3A2', 'DLG4', 'MAP1B', 'AKT1S1', 'NF1', 'KRAS', 'RAF1', 'PLCB1', 'EIF4G1', 'HCN1']",0.8083151240943924,0,0,31
52,Amino Acid metabolism WP3925,0.0803651076712929,1.5139862667148536,3.817024600294164,"['PDHX', 'ARG2', 'OAT', 'PDHA1', 'HIBADH', 'MCCC1', 'GOT2', 'EPRS', 'ADH5', 'GLS', 'ACLY', 'LARS2', 'LDHA', 'PKM', 'TDO2', 'AUH', 'ALDH18A1', 'BCAT1', 'GLUL', 'DLD']",0.8083151240943924,0,0,20
53,NO/cGMP/PKG mediated Neuroprotection WP4008,0.08144733512490197,1.8089838366119535,4.536567245750784,"['GUCY1A2', 'GRIN2A', 'GUCY1A1', 'BAD', 'DLG4', 'AKAP9', 'NEFL', 'PRKG2', 'NOS1', 'CAMK2G', 'PPID']",0.8083151240943924,0,0,11
54,Aryl Hydrocarbon Receptor Netpath WP2586,0.08293834470982651,1.7458627858627858,4.346600871206749,"['RB1', 'HSP90AA1', 'MAP2K1', 'PSRC1', 'AIP', 'NF1', 'EP300', 'CYP1B1', 'ARNT', 'KRAS', 'RAF1', 'NFE2L2']",0.8083151240943924,0,0,12
55,PDGF Pathway WP2526,0.08293834470982651,1.7458627858627858,4.346600871206749,"['TIAM1', 'MAPK8', 'MAP2K1', 'JUN', 'MAP3K1', 'CHUK', 'RASA1', 'ARFIP2', 'RAF1', 'JAK1', 'MAPK3', 'VAV2']",0.8083151240943924,0,0,12
56,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.08305623293446968,2.2055455635491605,5.487920948380194,"['FLT3', 'DNMT3A', 'EP300', 'ATM', 'TERF2', 'ETV6', 'MCL1']",0.8083151240943924,0,0,7
57,miRNAs involved in DNA damage response WP1545,0.08560174974755219,2.700010270103728,6.636759043105548,"['RAD52', 'CDK6', 'H2AFX', 'ABL1', 'ATM']",0.8184728703932622,0,0,5
58,Pancreatic adenocarcinoma pathway WP4263,0.08759147951576271,1.46094349798547,3.557501950398813,"['RB1', 'SMAD2', 'MAP2K1', 'CHUK', 'CDKN2A', 'BAD', 'GADD45A', 'TGFBR1', 'DUSP6', 'MAPK10', 'TIAM1', 'MAPK9', 'MAPK8', 'CDK6', 'AKT2', 'PAK6', 'KRAS', 'POLK', 'RAF1', 'PAK2', 'JAK1', 'MAPK3']",0.8230578678636323,0,0,22
59,IL-3 signaling pathway WP286,0.09725141099642733,1.733444404418828,4.039715544809477,"['MAP2K1', 'MAPK8', 'JUN', 'BAD', 'FYN', 'GAB2', 'PRKACA', 'RAF1', 'CBL', 'JAK1', 'MAPK3']",0.8657279167016979,0,0,11
60,Netrin-UNC5B signaling pathway WP4747,0.09725141099642733,1.733444404418828,4.039715544809477,"['MAP2K1', 'JUN', 'ARHGEF12', 'PPP2R1B', 'NTN4', 'FYN', 'RAF1', 'MAPK14', 'RLF', 'PLEKHH1', 'MAPK3']",0.8657279167016979,0,0,11
61,Rett syndrome causing genes WP4312,0.09770767014660708,1.604869466391284,3.7325656296632106,"['KDM5B', 'SRRM3', 'EIF2B2', 'CDKL5', 'SATB2', 'HTT', 'HDAC8', 'SMARCA2', 'GRIN2A', 'TAF1B', 'IMPDH2', 'TCF4', 'HIVEP2', 'GABRD']",0.8657279167016979,0,0,14
62,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.09848647859725737,3.023499820337765,7.007976769939761,"['MAPK8', 'MAP2K1', 'MAFK', 'NFE2L2']",0.8657279167016979,0,0,4
63,Alzheimer's disease WP2059,0.10397384078024496,1.4672496166096496,3.321289623695355,"['BAD', 'ITPR1', 'ATP2A2', 'ADAM10', 'PSEN1', 'APH1A', 'VMP1', 'PPP3CB', 'NCSTN', 'GRIN2A', 'PPP3CC', 'CDK5', 'NOS1', 'APBB1', 'PLCB1', 'ATF6', 'GAPDH', 'MAPK3', 'CDK5R1']",0.8722686655488427,0,0,19
64,7q11.23 copy number variation syndrome WP4932,0.1040320426801372,1.397544475068905,3.1627218632159053,"['RB1', 'ATPAF2', 'BECN1', 'CLTC', 'H2AFX', 'LIMK1', 'UBE2E1', 'HMGA1', 'DDX21', 'UBE2L6', 'VPS37A', 'HSPA2', 'MLXIPL', 'TBL2', 'MYBBP1A', 'BCL7B', 'WNT2', 'DLD', 'GAPDH', 'VPS28', 'CLASP1', 'FBN1', 'CLASP2', 'MAPK3']",0.8722686655488427,0,0,24
65,Gastrin signaling pathway WP4659,0.1040320426801372,1.397544475068905,3.1627218632159053,"['ITGB1', 'CHGA', 'MAP2K1', 'JUN', 'CHUK', 'ROCK1', 'IRS1', 'CDKN2A', 'BAD', 'ARHGEF28', 'RPS6', 'ARRB1', 'MAPK14', 'HDAC7', 'MAPK9', 'MAPK8', 'TCF4', 'FYN', 'KRAS', 'PRKD1', 'PRKACA', 'RAF1', 'LAMTOR3', 'MAPK3']",0.8722686655488427,0,0,24
66,T-cell receptor (TCR) signaling pathway WP69,0.10591451572100789,1.480569032926657,3.3240595381166296,"['MAP2K1', 'JUN', 'CD83', 'CHUK', 'PDPK1', 'ITPR1', 'CBLB', 'GAB2', 'CBL', 'MAPK14', 'MAPK9', 'MAPK8', 'FYN', 'RAF1', 'MAP3K7', 'MAP3K14', 'NCK1', 'MAPK3']",0.8745971373931712,0,0,18
67,Cell migration and invasion through p75NTR WP4561,0.11028723473487954,1.8904282115869018,4.167764867215325,"['EFNB2', 'NTRK2', 'TIAM1', 'JUN', 'EFNA3', 'ADAMTS13', 'KIDINS220', 'AKT2']",0.875617166857937,0,0,8
68,IL-1 signaling pathway WP195,0.11256038291298777,1.5575189325640102,3.4020348144320787,"['MAP2K3', 'MAP3K3', 'MAP2K1', 'JUN', 'MAP3K1', 'CHUK', 'MAPK14', 'MAPK9', 'MAPK8', 'IRAK2', 'TAB2', 'MAP3K7', 'MAP3K14', 'MAPK3']",0.875617166857937,0,0,14
69,Effects of nitric oxide WP1995,0.11315083802968424,7.556193895870736,16.465199635901655,"['HBA1', 'NOS1']",0.875617166857937,0,0,2
70,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.11434426474154091,1.7188267260287426,3.72734711260574,"['MAPK9', 'MAPK8', 'JUN', 'CHUK', 'AKT2', 'MAPK14', 'RAF1', 'MAP3K7', 'MAP3K14', 'MAPK3']",0.875617166857937,0,0,10
71,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.11447416123587692,1.6208494208494209,3.5130389989475455,"['MAPK9', 'MAP2K1', 'JUN', 'DLG1', 'CHUK', 'FYN', 'RAF1', 'CBL', 'MAP3K7', 'MAP3K14', 'NCK1', 'MAPK3']",0.875617166857937,0,0,12
72,Type II diabetes mellitus WP1584,0.11600510971944583,2.362284327821711,5.088646371937173,"['SURF1', 'MAPK8', 'IRS1', 'INSR', 'CACNA1A']",0.875617166857937,0,0,5
73,Ras signaling WP4223,0.11728450124886129,1.286022921339067,2.756143446255493,"['SHC4', 'RAB5B', 'FLT3', 'RASAL2', 'PLA2G6', 'RAP1B', 'MAPK9', 'GRIN2A', 'MAPK8', 'RASSF5', 'AKT2', 'ABL1', 'PAK6', 'PRKACA', 'PAK2', 'MAPK3', 'PDGFRA', 'NTRK2', 'MAP2K1', 'CHUK', 'BAD', 'INSR', 'RRAS2', 'KSR2', 'GAB2', 'GNG13', 'MAPK10', 'TIAM1', 'RASA1', 'RASA2', 'NF1', 'KRAS', 'RAF1', 'FGFR2', 'EXOC2', 'ARF6']",0.875617166857937,0,0,36
74,Ebstein-Barr virus LMP1 signaling WP262,0.12573676849095566,2.061782877316858,4.275240185811715,"['MAP3K3', 'HSP90AA1', 'MAPK8', 'CHUK', 'MAP3K7', 'MAP3K14']",0.9136871843676111,0,0,6
75,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.12573676849095566,2.061782877316858,4.275240185811715,"['SMAD2', 'MAPK8', 'MAPK14', 'TGFBR1', 'MAPK3', 'FBN1']",0.9136871843676111,0,0,6
76,Ciliary landscape WP4352,0.12752808428647222,1.2285012285012284,2.5299983657564913,"['RB1', 'DOCK5', 'TTC26', 'PSMD12', 'DDX5', 'CTBP2', 'GDI1', 'ZMYND19', 'IFT172', 'VPS4A', 'IQGAP1', 'EHBP1', 'EXOSC4', 'APMAP', 'NEFL', 'NEFM', 'TMED1', 'NINL', 'BBS5', 'EXOSC2', 'CEP290', 'IQCB1', 'ZYG11B', 'CNOT6L', 'RNGTT', 'EXOC8', 'DYNLT1', 'IFT140', 'RHBDD2', 'IFT80', 'COPS3', 'MYL6', 'EHD3', 'PSMC6', 'RABEP2', 'WDR60', 'VAPB', 'COPS2', 'GID8', 'EXOC4', 'ERF', 'MCM3', 'CD2BP2', 'ANKS6', 'DYNLRB1', 'YPEL5', 'IFT46', 'EXOC2']",0.9145106044227285,0,0,48
77,Common Pathways Underlying Drug Addiction WP2636,0.13391247889897143,1.5997977166925295,3.216503431432931,"['GRIA1', 'RAP1B', 'PPP1CC', 'GRIN2A', 'GRM5', 'MAP2K1', 'PRKACA', 'RAF1', 'ACTB', 'GRIA3', 'MAPK3']",0.9279384667680973,0,0,11
78,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.13487446320598132,1.7013498920086394,3.4085028083697475,"['MAPK9', 'MAPK8', 'MAP2K1', 'RPS6', 'FYN', 'GAB2', 'MAPK14', 'JAK1', 'MAPK3']",0.9279384667680973,0,0,9
79,Prolactin Signaling Pathway WP2037,0.1364513988684135,1.4290092258323306,2.8462816845177703,"['ITGB1', 'MAP2K1', 'JUN', 'IRS1', 'RPS6', 'GAB2', 'CBL', 'MAPK14', 'VAV2', 'MAPK9', 'MAPK8', 'FYN', 'RAF1', 'PPIA', 'YWHAG', 'JAK1', 'MAPK3']",0.9279384667680973,0,0,17
80,Regulation of toll-like receptor signaling pathway WP1449,0.13697750563299751,1.3698668561597727,2.7232111441861764,"['MAP2K3', 'USP7', 'MAP2K1', 'JUN', 'TICAM2', 'CHUK', 'MAPK14', 'RNF41', 'MAPK10', 'MAPK9', 'MAPK8', 'TBK1', 'RNF216', 'IRAK2', 'AKT2', 'SARM1', 'TAB2', 'TMED7', 'ZMYND11', 'MAP3K7', 'MAPK3']",0.9279384667680973,0,0,21
81,Osteopontin Signaling WP1434,0.13791379047379063,2.51934363396814,4.991138425146157,"['MAP2K1', 'CHUK', 'MAP3K14', 'MAPK3']",0.9279384667680973,0,0,4
82,Imatinib and Chronic Myeloid Leukemia WP3640,0.150732983373371,2.099608594935698,3.972974557597365,"['PDGFRA', 'GADD45A', 'ABL1', 'GAB2', 'SKP2']",0.9314714734571895,0,0,5
83,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.150732983373371,2.099608594935698,3.972974557597365,"['MAP3K1', 'ROCK1', 'FGF9', 'FGFR2', 'MAP3K4']",0.9314714734571895,0,0,5
84,MAPK pathway in congenital thyroid cancer WP4928,0.150732983373371,2.099608594935698,3.972974557597365,"['MAP2K1', 'JUN', 'KRAS', 'RAF1', 'MAPK3']",0.9314714734571895,0,0,5
85,TGF-beta Receptor Signaling WP560,0.15467972287139115,1.5403991888141744,2.874998895405246,"['SMAD2', 'MAPK9', 'ZEB2', 'JUN', 'ZFYVE9', 'EP300', 'ZNF423', 'SMAD5', 'TGFBR1', 'JAK1', 'MAPK3']",0.9314714734571895,0,0,11
86,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.15683756330807225,1.8897878460985258,3.5009163409497077,"['BECN1', 'PIK3R4', 'ATG4A', 'ATG13', 'ATG7', 'ATG5']",0.9314714734571895,0,0,6
87,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.15933123593461507,1.7639328537170265,3.2399389456681,"['PPP2CA', 'MAP2K1', 'FGF9', 'MAPK14', 'RAF1', 'ATG5', 'MAPK3']",0.9314714734571895,0,0,7
88,MTHFR deficiency WP4288,0.15933123593461507,1.7639328537170265,3.2399389456681,"['GRIN2A', 'PCYT1A', 'SGMS1', 'NDUFAF7', 'DNMT3A', 'EHMT1', 'CHPT1']",0.9314714734571895,0,0,7
89,Nanoparticle triggered autophagic cell death WP2509,0.15933123593461507,1.7639328537170265,3.2399389456681,"['VMP1', 'BECN1', 'INSR', 'ATG4A', 'AMBRA1', 'ATG7', 'ATG5']",0.9314714734571895,0,0,7
90,Physiological and pathological hypertrophy of the heart WP1528,0.15933123593461507,1.7639328537170265,3.2399389456681,"['MAP2K3', 'MAPK8', 'PPP3CB', 'JUN', 'LIFR', 'MAPK14', 'AGT']",0.9314714734571895,0,0,7
91,Lipid Metabolism Pathway WP3965,0.1597084661943036,1.6800607732597657,3.081912239032381,"['BCKDHA', 'ACLY', 'PRKAA1', 'PDHA1', 'PRKAR2B', 'PRKAR2A', 'AKT2', 'PRKACA']",0.9314714734571895,0,0,8
92,Nanoparticle-mediated activation of receptor signaling WP2643,0.1597084661943036,1.6800607732597657,3.081912239032381,"['ITGB1', 'MAPK10', 'MAPK9', 'MAPK8', 'MAP2K1', 'KRAS', 'MAPK14', 'RAF1']",0.9314714734571895,0,0,8
93,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.16903100701748988,1.3679391658345494,2.4317486676796713,"['SMAD2', 'MAP2K1', 'JUN', 'BAD', 'GADD45A', 'AXIN2', 'TGFBR1', 'MAPK10', 'MAPK9', 'MAPK8', 'TBK1', 'AKT2', 'KRAS', 'POLK', 'RAF1', 'EXOC2', 'MAPK3']",0.9314714734571895,0,0,17
94,Melanoma WP4685,0.17394234766745534,1.3751517338669992,2.405183520927441,"['RB1', 'MAP2K1', 'CDKN2A', 'BAD', 'GADD45A', 'GRM3', 'GRIN2A', 'CDK6', 'AKT2', 'NF1', 'KRAS', 'POLK', 'RAF1', 'LAMTOR3', 'VCL', 'MAPK3']",0.9314714734571895,0,0,16
95,Metabolic reprogramming in colon cancer WP4290,0.17696879366588494,1.4852434129271306,2.5721176134469137,"['ACLY', 'LDHA', 'PDHA1', 'PKM', 'PGAM1', 'GOT2', 'ENO1', 'PAICS', 'GAPDH', 'PSPH', 'GLS']",0.9314714734571895,0,0,11
96,Regulation of Microtubule Cytoskeleton WP2038,0.17696879366588494,1.4852434129271306,2.5721176134469137,"['TIAM1', 'ROCK1', 'CFL2', 'MAP1B', 'TAOK1', 'DVL1', 'LIMK1', 'ABL1', 'TPPP', 'PRKACA', 'CLASP1']",0.9314714734571895,0,0,11
97,Fas ligand pathway and stress induction of heat shock proteins WP314,0.18090212376962042,1.5121353979114152,2.585447812937632,"['RB1', 'MAPK8', 'DAXX', 'JUN', 'MAP3K1', 'FAF1', 'LMNA', 'PAK2', 'MAP3K7', 'ACTB']",0.9314714734571895,0,0,10
98,"GPCRs, Other WP117",0.18090212376962042,1.5121353979114152,2.585447812937632,"['CHRM3', 'GPR162', 'HTR1F', 'GPR88', 'OR2M4', 'ACKR1', 'CELSR2', 'CELSR3', 'GPR135', 'ADGRL3']",0.9314714734571895,0,0,10
99,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.18245269228640007,2.1592320722755507,3.6734245693402148,"['MAP3K1', 'CHUK', 'RAF1', 'MAP3K14']",0.9314714734571895,0,0,4
100,RAS and bradykinin pathways in COVID-19 WP4969,0.18245269228640007,2.1592320722755507,3.6734245693402148,"['ROCK1', 'SERPING1', 'NOS1', 'AGT']",0.9314714734571895,0,0,4
101,IL-2 signaling pathway WP49,0.1845493201702147,1.5463871981150599,2.613144674666702,"['MAP2K1', 'JUN', 'RPS6', 'FYN', 'GAB2', 'CBL', 'RAF1', 'JAK1', 'MAPK3']",0.9314714734571895,0,0,9
102,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.1877024496697309,1.591485009753603,2.662390951124387,"['MAPK8', 'JUN', 'TBK1', 'CHUK', 'DDX58', 'MAPK14', 'MAP3K7', 'JAK1']",0.9314714734571895,0,0,8
103,Kynurenine Pathway and links to Cellular Senescence WP5044,0.18917917365782405,1.8894680086268871,3.146078933059537,"['KLF5', 'TDO2', 'EIF2AK1', 'EIF2AK4', 'NOS1']",0.9314714734571895,0,0,5
104,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.18917917365782405,1.8894680086268871,3.146078933059537,"['JUN', 'ITPR1', 'LPP', 'VCL', 'MAPK3']",0.9314714734571895,0,0,5
105,Cannabinoid receptor signaling WP3869,0.19001721799583837,1.6535296762589928,2.7459184969945327,"['MAPK10', 'MAPK9', 'MAPK8', 'PRKAR2B', 'PRKACA', 'MAPK14', 'MAPK3']",0.9314714734571895,0,0,7
106,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.19001721799583837,1.6535296762589928,2.7459184969945327,"['RAB4A', 'NEFL', 'MFN2', 'KIF1B', 'RABAC1', 'RAB11A', 'DNM2']",0.9314714734571895,0,0,7
107,TGF-beta Signaling Pathway WP366,0.19083348918345167,1.2456124072110286,2.06317511249086,"['ITGB1', 'ROCK1', 'ZFYVE9', 'MAPK9', 'MAPK8', 'PRKAR2A', 'EP300', 'BTRC', 'MAP3K7', 'PAK2', 'NUP214', 'MAP2K3', 'SMAD2', 'MAP2K1', 'JUN', 'JUND', 'SMURF2', 'SMURF1', 'MAPK14', 'PIAS2', 'TGFBR1', 'PJA1', 'EID2', 'ZEB2', 'ZFYVE16', 'RAF1', 'DCP1A']",0.9314714734571895,0,0,27
108,Canonical and non-canonical Notch signaling WP3845,0.1908904903358598,1.7442535889137831,2.8885805127768753,"['HEY1', 'CHUK', 'CNTN6', 'ADAM10', 'PSEN1', 'MAML3']",0.9314714734571895,0,0,6
109,Gastric Cancer Network 1 WP2361,0.1908904903358598,1.7442535889137831,2.8885805127768753,"['CCNA1', 'INO80D', 'RNF216', 'CASTOR3', 'ACTL6A', 'CEP192']",0.9314714734571895,0,0,6
110,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.1908904903358598,1.7442535889137831,2.8885805127768753,"['PRKAA1', 'LDHA', 'PDHA1', 'RPS6', 'KEAP1', 'NFE2L2']",0.9314714734571895,0,0,6
111,MECP2 and Associated Rett Syndrome WP3584,0.1925471319961761,1.3444644933638077,2.2148900506081417,"['GRIA1', 'RBFOX1', 'ARHGEF26', 'RPS6', 'TET2', 'TET1', 'FGF5', 'FUT8', 'GPRIN1', 'TET3', 'SP3', 'NF1', 'SGK1', 'TARDBP', 'GRIA3', 'EZH2']",0.9314714734571895,0,0,16
112,Glucocorticoid Receptor Pathway WP2880,0.19507261464761827,1.4177027027027027,2.3170697732533716,"['AKAP13', 'RGS2', 'HSP90AA1', 'JUN', 'NAV3', 'ABHD2', 'ENC1', 'CDC42EP3', 'AMIGO2', 'BHLHE40', 'SPRY1', 'SLC19A2']",0.9314714734571895,0,0,12
113,RANKL/RANK signaling pathway WP2018,0.19507261464761827,1.4177027027027027,2.3170697732533716,"['MAPK9', 'MAP2K1', 'MAPK8', 'JUN', 'CHUK', 'AKT2', 'TAB2', 'GAB2', 'CBL', 'MAPK14', 'MAP3K7', 'MAPK3']",0.9314714734571895,0,0,12
114,Cells and molecules involved in local acute inflammatory response  WP4493,0.19536756230988825,3.777737881508079,6.168564524667158,"['ITGB1', 'C5']",0.9314714734571895,0,0,2
115,Spinal Cord Injury WP2431,0.21017351694742753,1.2829853943022296,2.0012286105422326,"['RB1', 'RTN4R', 'EPHA4', 'SEMA6A', 'GADD45A', 'XYLT1', 'MIF', 'TACR1', 'PLA2G6', 'RTN4', 'LTB4R', 'EFNB2', 'GJA1', 'C5', 'CHST11', 'PLXNA2', 'NOS1', 'ROS1', 'MAPK3']",0.9314714734571895,0,0,19
116,Wnt signaling pathway and pluripotency WP399,0.21017351694742753,1.2829853943022296,2.0012286105422326,"['JUN', 'CTBP2', 'LRRK2', 'PPP2R2A', 'AXIN2', 'PPP2R5C', 'LRP6', 'PPP2CA', 'MAPK10', 'MAPK9', 'PPP2R1B', 'PPP2R1A', 'PPP2R2B', 'DVL1', 'EP300', 'PRKD1', 'MAP3K7', 'WNT2', 'LDLR']",0.9314714734571895,0,0,19
117,G1 to S cell cycle control WP45,0.21157638357964093,1.3651666266121927,2.120334749156329,"['RB1', 'PRIM2', 'CDKN2A', 'GADD45A', 'RPA2', 'ORC5', 'CCNA1', 'CREB3', 'CDK6', 'CCNG2', 'MCM3', 'ATM', 'MNAT1']",0.9314714734571895,0,0,13
118,Disruption of postsynaptic signaling by CNV WP4875,0.21202086529514858,1.4790121138135037,2.294052188957355,"['NLGN1', 'GRIN2A', 'DLG1', 'DLG2', 'NRXN3', 'DLGAP1', 'CAMK2G', 'YWHAG', 'MAPK3']",0.9314714734571895,0,0,9
119,VEGFA-VEGFR2 Signaling Pathway WP3888,0.21285471396261998,1.114717098913089,1.7246294765591548,"['ITGB1', 'ARF4', 'KCNC3', 'FAF1', 'CLTC', 'LDB2', 'EPRS', 'SHB', 'HERPUD1', 'GJA1', 'RPS6KA5', 'BSG', 'SH3BGRL3', 'CHAC1', 'RPS11', 'IER5', 'NCK1', 'MAP2K3', 'ACOT9', 'MAP2K1', 'HSP90AA1', 'PDPK1', 'TRPC1', 'RPS6', 'ARNT', 'ADAM10', 'SND1', 'EPN1', 'VAV2', 'EWSR1', 'RHOJ', 'AKT1S1', 'ADAM9', 'PRKD1', 'EZR', 'ATP6V0D1', 'RAF1', 'ATF6', 'GAPDH', 'VCL', 'ARF6', 'HDAC4', 'PRKAA1', 'ROCK1', 'MAPKAP1', 'IQGAP1', 'CBL', 'HDAC9', 'GIGYF2', 'APOLD1', 'HDAC7', 'RAP1B', 'PPP2CA', 'MAPK9', 'LDHA', 'MAPK8', 'DNAJB4', 'MYO6', 'ABL1', 'DNAJB9', 'FLNB', 'FYN', 'EIF4E', 'PAK2', 'MAPK3', 'RBM39', 'JUN', 'RAB4A', 'LIMK1', 'PRRC2C', 'TRIP4', 'MICAL2', 'PDE4DIP', 'STAM', 'SOD2', 'MAPK14', 'SMARCA2', 'QKI', 'RAB11A', 'SPIRE1', 'PTPN9', 'COPG1', 'EIF4G1']",0.9314714734571895,0,0,83
120,Hepatitis B infection WP4666,0.2131205823026568,1.217365945515825,1.881922557071916,"['MAPK9', 'MAPK8', 'TBK1', 'AKT2', 'EP300', 'MAP3K7', 'JAK1', 'MAPK3', 'MAP2K3', 'SMAD2', 'MAP2K1', 'JUN', 'TICAM2', 'MAP3K1', 'ATP6AP1', 'CHUK', 'DDX58', 'BAD', 'NFATC3', 'MAPK14', 'TGFBR1', 'DDB1', 'MAPK10', 'CREB3', 'VDAC3', 'TAB2', 'KRAS', 'RAF1']",0.9314714734571895,0,0,28
121,Pathways in clear cell renal cell carcinoma WP4018,0.21721719684114754,1.284163617408369,1.9607348747546625,"['PDGFRA', 'SETD2', 'BHLHE41', 'ARNT', 'ENO1', 'ENO2', 'RPTOR', 'ACLY', 'LDHB', 'TOX2', 'LDHA', 'PKM', 'AKT1S1', 'EP300', 'CEP290', 'GAPDH', 'PFKM', 'PSPH']",0.9314714734571895,0,0,18
122,PDGFR-beta pathway WP3972,0.21758771282284398,1.511766822598057,2.305676056122685,"['MAPK8', 'MAP2K1', 'JUN', 'MAP3K1', 'RASA1', 'RAF1', 'JAK1', 'MAPK3']",0.9314714734571895,0,0,8
123,Integrin-mediated Cell Adhesion WP185,0.22098527087311975,1.2604505481267316,1.9028508005580285,"['MAP2K3', 'ITGB1', 'GIT2', 'MAP2K1', 'ROCK1', 'PDPK1', 'SORBS1', 'VAV2', 'RAP1B', 'MAPK10', 'CAPNS1', 'AKT2', 'ITGB8', 'PAK6', 'FYN', 'RAF1', 'ARHGEF7', 'PAK2', 'VCL', 'MAP2K5']",0.9314714734571895,0,0,20
124,Sphingolipid pathway WP1422,0.2228472127944455,1.556115107913669,2.3361471957283535,"['PPP2CA', 'UGCG', 'CERS5', 'CERS6', 'SGMS1', 'SERINC1', 'SGPP2']",0.9314714734571895,0,0,7
125,15q13.3 copy number variation syndrome WP4942,0.2240667421808685,2.266810344827586,3.3907205635288284,"['OTUD7A', 'FYN', 'FAN1']",0.9314714734571895,0,0,3
126,NLR Proteins WP288,0.2240667421808685,2.266810344827586,3.3907205635288284,"['MAPK8', 'CHUK', 'MAP3K7']",0.9314714734571895,0,0,3
127,Splicing factor NOVA regulated synaptic proteins WP4148,0.22566826647254742,1.3859630163304515,2.063268181660953,"['MAPK9', 'CADM3', 'EPB41L3', 'TERF2IP', 'GRIK2', 'NCDN', 'ANK3', 'STX2', 'CAMK2G', 'GPHN', 'CLASP1']",0.9314714734571895,0,0,11
128,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.22743525331219663,1.6195099398982895,2.3983155597673447,"['RPS6', 'PRKACA', 'MAPK14', 'SGK1', 'RAF1', 'MAPK3']",0.9314714734571895,0,0,6
129,NRF2-ARE regulation WP4357,0.22743525331219663,1.6195099398982895,2.3983155597673447,"['AIMP2', 'MAPK8', 'INSR', 'KEAP1', 'FYN', 'NFE2L2']",0.9314714734571895,0,0,6
130,Signal Transduction of S1P Receptor WP26,0.22743525331219663,1.6195099398982895,2.3983155597673447,"['AKT2', 'GNAI3', 'S1PR3', 'PLCB1', 'PIK3C2B', 'MAPK3']",0.9314714734571895,0,0,6
131,Urea cycle and associated pathways WP4595,0.22743525331219663,1.6195099398982895,2.3983155597673447,"['LDHB', 'OAT', 'GOT2', 'NOS1', 'SLC25A12', 'SLC25A13']",0.9314714734571895,0,0,6
132,Glioblastoma signaling pathways WP2261,0.2284978583439736,1.2603564547206165,1.8605740447176389,"['RB1', 'MAP2K3', 'PDGFRA', 'MAP2K1', 'IRS1', 'PDPK1', 'CDKN2A', 'CBL', 'PIK3C2B', 'CDK6', 'AKT2', 'NF1', 'EP300', 'ATM', 'KRAS', 'RAF1', 'MAP2K5', 'FGFR2', 'MAPK3']",0.9314714734571895,0,0,19
133,Wnt signaling WP428,0.2284978583439736,1.2603564547206165,1.8605740447176389,"['JUN', 'CTBP2', 'SERPINF1', 'CSNK2A2', 'NFATC3', 'PRICKLE1', 'SENP2', 'CXXC4', 'LRP6', 'MAPK9', 'PPP3CB', 'MAPK8', 'PPP3CC', 'DVL1', 'ROR2', 'PLCB1', 'MAP3K7', 'WNT2', 'CAMK2G']",0.9314714734571895,0,0,19
134,Methionine De Novo and Salvage Pathway WP3580,0.23063545013375408,1.7175348016469512,2.519480917870486,"['MSRA', 'AHCY', 'AMD1', 'MSRB2', 'MSRB3']",0.9314714734571895,0,0,5
135,Translation Factors WP107,0.23461206066824128,1.3281435725559734,1.925571683771249,"['EIF4A2', 'EIF5A', 'EIF2B3', 'EIF2B2', 'EIF2AK1', 'EEF2', 'GSPT2', 'EEF1G', 'EEF2K', 'EIF2S3', 'EIF3G', 'EIF4E', 'EIF4G1']",0.9314714734571895,0,0,13
136,Regulation of Actin Cytoskeleton WP51,0.2355715539509803,1.1921800611659363,1.7235830850379334,"['CHRM3', 'CHRM1', 'ROCK1', 'PIK3R4', 'IQGAP1', 'ACTB', 'FGD1', 'PIK3C2B', 'FGF5', 'FGF9', 'CFL2', 'PAK6', 'PIP4K2C', 'PAK2', 'WASF2', 'MAPK3', 'PDGFRA', 'MAP2K1', 'GSN', 'LIMK1', 'RRAS2', 'SSH2', 'SSH1', 'KRAS', 'EZR', 'RAF1', 'ARHGEF7', 'VCL', 'FGFR2']",0.9314714734571895,0,0,29
137,Pathways Regulating Hippo Signaling WP4540,0.23640197199932853,1.2602624292765139,1.8175777623193903,"['SMAD2', 'PDGFRA', 'NTRK2', 'PRKAA1', 'FLT3', 'INSR', 'GNAI3', 'CDH8', 'CDH6', 'LATS1', 'CDH20', 'PRKAR2B', 'PRKAR2A', 'CDH10', 'CDH12', 'PRKACA', 'PLCB1', 'FGFR2']",0.9314714734571895,0,0,18
138,Head and Neck Squamous Cell Carcinoma WP4674,0.24063972780370002,1.2887396694214877,1.8357508530700926,"['RB1', 'PRKAA1', 'PDPK1', 'CDKN2A', 'MAPKAP1', 'RPS6', 'KEAP1', 'RPTOR', 'CDK6', 'AKT2', 'KRAS', 'CSMD3', 'EIF4E', 'FGFR2', 'NFE2L2']",0.9314714734571895,0,0,15
139,Amyotrophic lateral sclerosis (ALS) WP2447,0.2409861977201169,1.4172516198704104,2.016771189714802,"['GRIA1', 'PPP3CB', 'DAXX', 'PPP3CC', 'BAD', 'NEFL', 'NEFM', 'NOS1', 'MAPK14']",0.9314714734571895,0,0,9
140,Ferroptosis WP4313,0.2409861977201169,1.4172516198704104,2.016771189714802,"['PRNP', 'MAP1LC3B', 'FTH1', 'PCBP1', 'VDAC3', 'ACSL4', 'ATG7', 'ATG5', 'FTL']",0.9314714734571895,0,0,9
141,Neural Crest Cell Migration in Cancer WP4565,0.2409861977201169,1.4172516198704104,2.016771189714802,"['NTRK2', 'TIAM1', 'JUN', 'SORT1', 'KIDINS220', 'AKT2', 'PIK3R4', 'PAK6', 'PAK2']",0.9314714734571895,0,0,9
142,DNA damage response WP707,0.24934373178358105,1.2907390956347355,1.792737069176718,"['RB1', 'GADD45A', 'H2AFX', 'RPA2', 'RAD52', 'PIDD1', 'CDK6', 'RRM2B', 'CDK5', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'RAD9A']",0.947496935091178,0,0,14
143,Resistin as a regulator of inflammation WP4481,0.25746128993327505,1.4695243804956035,1.993976912387356,"['CHUK', 'AKT2', 'ITPR1', 'MAPK14', 'PLCB1', 'PLCD4', 'MAPK3']",0.947496935091178,0,0,7
144,ErbB signaling pathway WP673,0.2579443077743025,1.2195576902899379,1.6525147912377443,"['SHC4', 'MAP2K1', 'JUN', 'PDPK1', 'BAD', 'CBLB', 'NRG2', 'CBL', 'MAPK10', 'MAPK9', 'MAPK8', 'AKT2', 'ABL1', 'PAK6', 'KRAS', 'RAF1', 'PAK2', 'CAMK2G', 'NCK1', 'MAPK3']",0.947496935091178,0,0,20
145,AGE/RAGE pathway WP2324,0.2585812730866407,1.2930691002921868,1.7489344459772012,"['SMAD2', 'MAP2K1', 'JUN', 'CHUK', 'ROCK1', 'IRS1', 'INSR', 'MAPK14', 'MAPK9', 'MAPK8', 'EZR', 'RAF1', 'MAPK3']",0.947496935091178,0,0,13
146,Genes related to primary cilium development (based on CRISPR) WP4536,0.25922261328889584,1.1940110863477913,1.6119962496891593,"['DYNC2H1', 'TTC26', 'DYNLT1', 'IFT140', 'IFT172', 'CEP295', 'CEP120', 'TULP3', 'KATNB1', 'IFT80', 'CPLANE1', 'MIB1', 'ARL13B', 'WDR60', 'KIAA0753', 'CDK20', 'TRAPPC11', 'FGFR1OP', 'WDPCP', 'CEP192', 'IFT46', 'PIBF1', 'BBS5', 'CEP44']",0.947496935091178,0,0,24
147,Kit receptor signaling pathway WP304,0.2684196354966949,1.295814671814672,1.7042602754694156,"['RPS6KA3', 'MAP2K1', 'MAPK8', 'BAD', 'RPS6', 'EP300', 'FYN', 'GAB2', 'RAF1', 'CBL', 'MAPK14', 'MAPK3']",0.947496935091178,0,0,12
148,ATM Signaling Pathway WP2516,0.2712205365938269,1.3604319654427646,1.7751229196412759,"['PIDD1', 'MAPK9', 'JUN', 'GADD45A', 'H2AFX', 'ABL1', 'TLK1', 'ATM', 'RAD9A']",0.947496935091178,0,0,9
149,Toll-like Receptor Signaling Pathway WP75,0.2727894677878883,1.2598870056497176,1.6366624657116107,"['MAP2K3', 'MAP2K1', 'JUN', 'TICAM2', 'CHUK', 'MAPK14', 'MAPK10', 'MAPK9', 'MAPK8', 'TBK1', 'AKT2', 'TAB2', 'MAP3K7', 'MAPK3']",0.947496935091178,0,0,14
150,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.2743432318742818,1.574257129163671,2.036105263816113,"['RAB5B', 'RRAS2', 'KRAS', 'RAF1', 'MAPK3']",0.947496935091178,0,0,5
151,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.2743432318742818,1.574257129163671,2.036105263816113,"['PYGO1', 'FLT3', 'AXIN2', 'LRP6', 'RUNX1T1']",0.947496935091178,0,0,5
152,Phytochemical activity on NRF2 transcriptional activation WP3,0.28193285649276567,1.679083323352098,2.125864449237827,"['AIMP2', 'MAPK8', 'KEAP1', 'NFE2L2']",0.947496935091178,0,0,4
153,TP53 network WP1742,0.28193285649276567,1.679083323352098,2.125864449237827,"['CDKN2A', 'GADD45A', 'ABL1', 'ATM']",0.947496935091178,0,0,4
154,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.28194200010649934,1.3740717720566586,1.7396489294358402,"['MAP2K1', 'STAR', 'AKT2', 'ARRB1', 'KRAS', 'RAF1', 'PLCB1', 'MAPK3']",0.947496935091178,0,0,8
155,Acetylcholine Synthesis WP528,0.28204548992655565,2.5182525433871934,3.187319278368507,"['PCYT1A', 'PDHA1']",0.947496935091178,0,0,2
156,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.28204548992655565,2.5182525433871934,3.187319278368507,"['GSTP1', 'COX5A']",0.947496935091178,0,0,2
157,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.28204548992655565,2.5182525433871934,3.187319278368507,"['PRKAA1', 'SIX4']",0.947496935091178,0,0,2
158,Molybdenum cofactor (Moco) biosynthesis WP4507,0.28204548992655565,2.5182525433871934,3.187319278368507,"['SUOX', 'GPHN']",0.947496935091178,0,0,2
159,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.28204548992655565,2.5182525433871934,3.187319278368507,"['NKRF', 'FYN']",0.947496935091178,0,0,2
160,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.28204548992655565,2.5182525433871934,3.187319278368507,"['JAK1', 'MAPK3']",0.947496935091178,0,0,2
161,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.283367877489515,1.2597933189137227,1.5886110975854428,"['ITGB1', 'ATP2A2', 'ACTB', 'CACNB2', 'GJA1', 'CACNG8', 'SGCD', 'CACNB4', 'LMNA', 'ITGB8', 'DMD', 'CTNNA2', 'CACNG2']",0.947496935091178,0,0,13
162,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.2850243901702014,1.1668499298236203,1.464607304980908,"['THRB', 'ATP1A3', 'RORA', 'ECE1', 'HDAC9', 'HSPD1', 'GJA1', 'DEAF1', 'PRKAR2B', 'PRKAR2A', 'EP300', 'TPPP', 'PKNOX1', 'PRKACA', 'YWHAG', 'GABRA1', 'NTRK2', 'JUN', 'TACR1', 'HADHB', 'AR', 'BHLHE40', 'SP3', 'GAPDH', 'CC2D1A']",0.947496935091178,0,0,25
163,Cytosine methylation WP3585,0.28685687025696216,1.8888290229885059,2.358716603139002,"['TET3', 'TET2', 'TET1']",0.947496935091178,0,0,3
164,Estrogen Receptor Pathway WP2881,0.28685687025696216,1.8888290229885059,2.358716603139002,"['JUN', 'GPAM', 'CYP1B1']",0.947496935091178,0,0,3
165,Matrix Metalloproteinases WP129,0.28685687025696216,1.8888290229885059,2.358716603139002,"['BSG', 'TIMP2', 'TCF20']",0.947496935091178,0,0,3
166,PI3K-Akt signaling pathway WP4172,0.2895777511867798,1.110996806569343,1.3768932803805196,"['ITGB1', 'PRKAA1', 'PHLPP1', 'CHRM1', 'IRS1', 'FLT3', 'LAMA4', 'PPP2R2A', 'THBS4', 'THBS3', 'RPTOR', 'GYS2', 'PPP2CA', 'FGF5', 'GYS1', 'PPP2R1B', 'FGF9', 'PPP2R1A', 'AKT2', 'PDGFD', 'THEM4', 'ITGB8', 'EIF4E', 'JAK1', 'MCL1', 'MAPK3', 'PDGFRA', 'NTRK2', 'MAP2K1', 'HSP90AA1', 'CHUK', 'PDPK1', 'BAD', 'INSR', 'RPS6', 'VEGFD', 'PPP2R5D', 'PPP2R5C', 'GNG13', 'CREB3', 'EFNA3', 'CDK6', 'PPP2R2B', 'KRAS', 'SGK1', 'RAF1', 'FGFR2']",0.9507221349204518,0,0,47
167,Folate Metabolism WP176,0.29347548450994226,1.392048466489966,1.7065973684535096,"['AHCY', 'RFK', 'INSR', 'NOS1', 'HBA1', 'SOD2', 'LDLR']",0.9577493356761588,0,0,7
168,miRNA regulation of DNA damage response WP1530,0.2969351360846469,1.2304698965942351,1.4940876880692222,"['RB1', 'GADD45A', 'H2AFX', 'RPA2', 'RAD52', 'PIDD1', 'CDK6', 'RRM2B', 'CDK5', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'RAD9A']",0.9632717212269795,0,0,14
169,Hepatitis C and Hepatocellular Carcinoma WP3646,0.30248459888404333,1.3079830536633992,1.5639879264313687,"['UCHL1', 'MAPK8', 'JUN', 'CTTN', 'MAPK14', 'TGFBR1', 'JAK1', 'VAV2', 'MAPK3']",0.9751139017375623,0,0,9
170,Estrogen signaling pathway WP712,0.3059531691690333,1.4168015102481122,1.6779509418396157,"['MAPK9', 'MAP2K1', 'JUN', 'CHUK', 'MAPK14', 'PRKACA']",0.9751139017375623,0,0,6
171,Sphingolipid Metabolism (integrated pathway) WP4726,0.3059531691690333,1.4168015102481122,1.6779509418396157,"['UGCG', 'CERS5', 'CERS6', 'SGMS1', 'DEGS1', 'SGPP2']",0.9751139017375623,0,0,6
172,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3195377130578538,1.4530221755239727,1.6577239024008974,"['H2AFX', 'H2AFV', 'DUSP6', 'MAPK3', 'EZH2']",0.9823722458955215,0,0,5
173,miRNAs involvement in the immune response in sepsis WP4329,0.3195377130578538,1.4530221755239727,1.6577239024008974,"['MAPK8', 'CHUK', 'TAB2', 'MAPK14', 'MAP3K7']",0.9823722458955215,0,0,5
174,Monoamine Transport WP727,0.3195377130578538,1.4530221755239727,1.6577239024008974,"['UNC13B', 'TDO2', 'NOS1', 'MAPK14', 'AGT']",0.9823722458955215,0,0,5
175,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3195377130578538,1.4530221755239727,1.6577239024008974,"['MAP2K1', 'ITPR1', 'KRAS', 'RAF1', 'MAPK3']",0.9823722458955215,0,0,5
176,G Protein Signaling Pathways WP35,0.3289234324821876,1.1581612437068804,1.2877945598450031,"['GNAZ', 'PDE1C', 'PDE1A', 'ITPR1', 'GNAI3', 'ADCY5', 'GNG13', 'AKAP12', 'AKAP13', 'PPP3CC', 'AKAP11', 'PRKAR2B', 'PRKAR2A', 'AKAP9', 'KRAS', 'PRKD1', 'PDE7B', 'PRKACA', 'PDE8A']",0.9823722458955215,0,0,19
177,Intraflagellar transport proteins binding to dynein WP4532,0.3304960404663766,1.3223201438848922,1.4640207641558183,"['DYNC2H1', 'DYNLT1', 'IFT140', 'WDR60', 'IFT80', 'DYNLRB1', 'IFT46']",0.9823722458955215,0,0,7
178,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3304960404663766,1.3223201438848922,1.4640207641558183,"['ATF1', 'CREB3', 'CAMK1D', 'STAR', 'ITPR1', 'CAMK2G', 'AGT']",0.9823722458955215,0,0,7
179,Glycogen Synthesis and Degradation WP500,0.33453108252776165,1.2594192464602831,1.379096166609152,"['PPP2CA', 'GYS2', 'GYS1', 'PPP2R1B', 'PPP2R1A', 'PPP2R2B', 'PPP2R2A', 'PPP2R5D', 'PPP2R5C']",0.9823722458955215,0,0,9
180,Oncostatin M Signaling Pathway WP2374,0.3348945086112078,1.198111382699984,1.3106616022638762,"['MAP2K1', 'JUND', 'IRS1', 'RPS6', 'LIFR', 'MAPK14', 'MAPK9', 'MAPK8', 'KRAS', 'RAF1', 'LDLR', 'JAK1', 'MAPK3']",0.9823722458955215,0,0,13
181,16p11.2 distal deletion syndrome WP4950,0.34687173205984195,1.3333333333333333,1.4117336208194144,"['RAB4A', 'RABEP2', 'INSR', 'TUFM', 'VAV2', 'SDCCAG8']",0.9823722458955215,0,0,6
182,Sleep regulation WP3591,0.34687173205984195,1.3333333333333333,1.4117336208194144,"['NLGN1', 'GRIN2A', 'AHCY', 'STAR', 'BTBD9', 'NPAS2']",0.9823722458955215,0,0,6
183,Wnt signaling in kidney disease WP4150,0.34687173205984195,1.3333333333333333,1.4117336208194144,"['MAPK10', 'MAPK9', 'MAPK8', 'DVL1', 'WNT2', 'LRP6']",0.9823722458955215,0,0,6
184,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.3468793385588578,1.175557959690668,1.2446552428335447,"['JUN', 'CTBP2', 'SERPINF1', 'CSNK2A2', 'AXIN2', 'SENP2', 'CXXC4', 'LRP6', 'CDK6', 'DVL1', 'ROR2', 'MAP3K7', 'WNT2', 'EZH2']",0.9823722458955215,0,0,14
185,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.3491460796784576,1.193172119487909,1.2555331146746853,"['GRIA1', 'PPP2CA', 'MAP2K1', 'MAPK8', 'JUN', 'DVL1', 'NEFL', 'NEFM', 'NOS1', 'RAF1', 'CBL', 'NCK1']",0.9823722458955215,0,0,12
186,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.35041665144832085,1.2593258966054937,1.3205699370781048,"['ITGB1', 'RPTOR', 'SMAD2', 'EIF2B2', 'IRS1', 'MAPKAP1', 'AKT1S1', 'EIF4E']",0.9823722458955215,0,0,8
187,G13 Signaling Pathway WP524,0.35041665144832085,1.2593258966054937,1.3205699370781048,"['MAPK10', 'ROCK1', 'CFL2', 'TNK2', 'LIMK1', 'ARHGDIG', 'IQGAP1', 'MAP3K4']",0.9823722458955215,0,0,8
188,Hedgehog Signaling Pathway WP4249,0.35041665144832085,1.2593258966054937,1.3205699370781048,"['CSNK1G3', 'SMURF2', 'SMURF1', 'GPR161', 'SPOP', 'FBXL17', 'ARRB1', 'PRKACA']",0.9823722458955215,0,0,8
189,Signaling of Hepatocyte Growth Factor Receptor WP313,0.35041665144832085,1.2593258966054937,1.3205699370781048,"['ITGB1', 'RAP1B', 'MAPK8', 'MAP2K1', 'JUN', 'RASA1', 'RAF1', 'MAPK3']",0.9823722458955215,0,0,8
190,ATM Signaling Network in Development and Disease  WP3878,0.35057693873840223,1.2187670612287569,1.2774812682636258,"['HDAC4', 'RNF168', 'PRKAA1', 'ATMIN', 'CDK5', 'H2AFX', 'ATM', 'CEP63', 'RNF40', 'CDK5R1']",0.9823722458955215,0,0,10
191,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.35057693873840223,1.2187670612287569,1.2774812682636258,"['RB1', 'MAP2K3', 'PDGFRA', 'HSP90AA1', 'MAPK8', 'JUN', 'CDKN2A', 'MAPK14', 'MCL1', 'NFE2L2']",0.9823722458955215,0,0,10
192,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.3541060374592423,1.1471054667354306,1.1908777149522076,"['SHC4', 'PDGFRA', 'MAP2K1', 'PDPK1', 'BAD', 'RPS6', 'RRAS2', 'NRG2', 'AKT2', 'PDGFD', 'NF1', 'KRAS', 'RAF1', 'EIF4E', 'FGFR2', 'JAK1', 'MAPK3']",0.9823722458955215,0,0,17
193,MET in type 1 papillary renal cell carcinoma WP4205,0.36137450566538754,1.1694733408864628,1.1903372675437303,"['MAP2K1', 'JUN', 'BAD', 'CBL', 'RAP1B', 'MAPK8', 'AKT2', 'PAK6', 'KRAS', 'STRN', 'RAF1', 'PAK2', 'MAPK3']",0.9823722458955215,0,0,13
194,Angiogenesis WP1539,0.36548313895743134,1.3491065009756598,1.3579230904460666,"['PDGFRA', 'TIMP2', 'ARNT', 'MAPK14', 'FGFR2']",0.9823722458955215,0,0,5
195,IL-7 signaling pathway WP205,0.36548313895743134,1.3491065009756598,1.3579230904460666,"['MAP2K1', 'BAD', 'FYN', 'JAK1', 'MAPK3']",0.9823722458955215,0,0,5
196,Monoamine GPCRs WP58,0.36548313895743134,1.3491065009756598,1.3579230904460666,"['CHRM3', 'CHRM1', 'HTR1E', 'HTR1F', 'ADRA2C']",0.9823722458955215,0,0,5
197,Integrated breast cancer pathway WP1984,0.3661790840453909,1.095964467005076,1.1010418123674874,"['ATF1', 'RB1', 'USP38', 'GDI1', 'IRS1', 'MYCBP2', 'JAKMIP1', 'IMPA1', 'ABL1', 'EP300', 'JAK1', 'SMAD2', 'JUN', 'CHUK', 'GADD45A', 'BAD', 'NCOA3', 'PPP4R3A', 'TGFBR1', 'CDC25B', 'HIPK2', 'AR', 'ITPKC', 'NF1', 'ATM', 'KRAS', 'ZNF655', 'MAP3K13', 'BMPR1A']",0.9823722458955215,0,0,29
198,Interleukin-11 Signaling Pathway WP2332,0.36711076751285715,1.2143242826288183,1.2168642332793704,"['ATF1', 'MAP2K1', 'CHUK', 'PDPK1', 'RPS6', 'FYN', 'RAF1', 'JAK1', 'MAPK3']",0.9823722458955215,0,0,9
199,ACE Inhibitor Pathway WP554,0.36771364800492917,1.8885098743267505,1.8893611657321887,"['ATP6AP2', 'AGT']",0.9823722458955215,0,0,2
200,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.36771364800492917,1.8885098743267505,1.8893611657321887,"['H6PD', 'STAR']",0.9823722458955215,0,0,2
201,LDLRAD4 and what we know about it WP4904,0.36771364800492917,1.8885098743267505,1.8893611657321887,"['SMAD2', 'TGFBR1']",0.9823722458955215,0,0,2
202,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.36771364800492917,1.8885098743267505,1.8893611657321887,"['AHCY', 'ADK']",0.9823722458955215,0,0,2
203,Peroxiredoxin 2 induced ovarian failure WP4873,0.36771364800492917,1.8885098743267505,1.8893611657321887,"['MAPK10', 'STAR']",0.9823722458955215,0,0,2
204,Pilocytic astrocytoma WP2253,0.36771364800492917,1.8885098743267505,1.8893611657321887,"['NF1', 'RAF1']",0.9823722458955215,0,0,2
205,COVID-19 adverse outcome pathway WP4891,0.37495013836835955,3.776740847092606,3.7048401091569394,['AGT'],0.996818660540273,0,0,1
206,Eukaryotic Transcription Initiation WP405,0.3814416809647736,1.1805680590565357,1.1378283168318681,"['POLR2A', 'TAF13', 'POLR2C', 'TAF9', 'POLR1E', 'TAF7', 'GTF2H1', 'POLR3H', 'TAF6', 'MNAT1']",0.9982955078535104,0,0,10
207,ERK Pathway in Huntington's Disease WP3853,0.3872250081615112,1.3735341194917192,1.3031395872356555,"['NTRK2', 'RPS6KA5', 'HTT', 'RAF1']",0.9982955078535104,0,0,4
208,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.3872250081615112,1.3735341194917192,1.3031395872356555,"['ACADVL', 'SCP2', 'ACSL4', 'SLC25A20']",0.9982955078535104,0,0,4
209,Neovascularisation processes WP4331,0.3882132273204373,1.2591393982979744,1.1913983727615343,"['SMAD2', 'MAPK9', 'MAPK8', 'SMAD5', 'TGFBR1', 'MAPK3']",0.9982955078535104,0,0,6
210,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.3939764565153745,1.1543087576048672,1.075197198621483,"['MAPK10', 'MAPK9', 'MAPK8', 'TBK1', 'TKFC', 'MAP3K1', 'CHUK', 'DDX58', 'MAPK14', 'MAP3K7', 'ATG5']",0.9982955078535104,0,0,11
211,Metapathway biotransformation Phase I and II WP702,0.4015009880641082,1.0951011664388262,0.9993294056666141,"['GSTM4', 'GSTM3', 'GLYATL2', 'NAA30', 'GSTP1', 'KCNAB1', 'KCNAB2', 'HS6ST1', 'NAT14', 'HS6ST2', 'HS6ST3', 'GSTZ1', 'CYP2U1', 'CHST11', 'NDST3', 'CYP1B1', 'CHST1', 'NAT8L', 'GAL3ST3', 'CHST2']",0.9982955078535104,0,0,20
212,Leptin signaling pathway WP2034,0.4074857118415391,1.1111111111111112,0.9974993443127644,"['MAP2K1', 'PRKAA1', 'CHUK', 'ROCK1', 'IRS1', 'BAD', 'RPS6', 'MAPK14', 'MAPK8', 'CFL2', 'FYN', 'RAF1', 'EIF4E', 'JAK1', 'MAPK3']",0.9982955078535104,0,0,15
213,EPO Receptor Signaling WP581,0.41149908630632986,1.2590462497004553,1.117968202746095,"['MAP2K1', 'IRS1', 'RASA1', 'RAF1', 'MAPK3']",0.9982955078535104,0,0,5
214,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.41149908630632986,1.2590462497004553,1.117968202746095,"['TICAM2', 'CHUK', 'IRAK2', 'RASSF5', 'CBLB']",0.9982955078535104,0,0,5
215,PKC-gamma calcium signaling pathway in ataxia WP4760,0.41149908630632986,1.2590462497004553,1.117968202746095,"['GRIA1', 'ITPR1', 'CACNA1A', 'PLCB1', 'GRIA3']",0.9982955078535104,0,0,5
216,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.413778426416686,1.4163523706896552,1.2498242454364867,"['MADD', 'MYRIP', 'SYTL3']",0.9982955078535104,0,0,3
217,Homologous recombination WP186,0.413778426416686,1.4163523706896552,1.2498242454364867,"['RAD52', 'ATM', 'RAD54B']",0.9982955078535104,0,0,3
218,Hypertrophy Model WP516,0.413778426416686,1.4163523706896552,1.2498242454364867,"['JUND', 'ADAM10', 'EIF4E']",0.9982955078535104,0,0,3
219,Leptin Insulin Overlap WP3935,0.413778426416686,1.4163523706896552,1.2498242454364867,"['PDPK1', 'IRS1', 'INSR']",0.9982955078535104,0,0,3
220,RalA downstream regulated genes WP2290,0.413778426416686,1.4163523706896552,1.2498242454364867,"['EXOC8', 'KRAS', 'EXOC2']",0.9982955078535104,0,0,3
221,Ebola Virus Pathway on Host WP4217,0.42298345776832447,1.0793536062780733,0.9286998127285093,"['ITGB1', 'VPS18', 'GSN', 'DDX58', 'CLTC', 'VPS4A', 'DAB2IP', 'IQGAP1', 'ACTB', 'VAV2', 'TIAM1', 'TBK1', 'C1QBP', 'RASA2', 'TYRO3', 'VPS11', 'EP300', 'FLNB', 'TOP1', 'MAPK3']",0.9982955078535104,0,0,20
222,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.42418865502234915,1.1017700444764995,0.9448526291778184,"['HSPA9', 'PSMD12', 'TUBB', 'UBE2L6', 'HSPA2', 'TUBB4B', 'TUBB4A', 'TUBA4A', 'TUBA1B', 'PSMC6', 'PSMC3', 'PSMD2', 'PSMD3', 'STUB1']",0.9982955078535104,0,0,14
223,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.43250397415500286,1.0896395271395272,0.9132963673121492,"['MAP2K1', 'THRB', 'BAD', 'RPS6', 'SLC16A10', 'MAPK14', 'RPTOR', 'CREB3', 'RPS6KA6', 'AKT1S1', 'PRKG2', 'PRKACA', 'RAF1', 'PLCB1', 'MAP4K5']",0.9982955078535104,0,0,15
224,NRF2 pathway WP2884,0.4380598818465117,1.0712190492623588,0.8841838405528069,"['GSTM4', 'GSTM3', 'CBR1', 'HSP90AA1', 'SLC6A17', 'SRXN1', 'SLC2A13', 'GSTP1', 'SLC39A11', 'KEAP1', 'SLC2A8', 'SLC2A9', 'SLC6A6', 'SLC6A9', 'FTH1', 'SLC39A6', 'SLC39A1', 'FTL', 'NFE2L2']",0.9982955078535104,0,0,19
225,One-carbon metabolism WP241,0.43942150797684565,1.258953168044077,1.0352323704524191,"['AHCYL2', 'AHCY', 'DNMT3A', 'GLRX']",0.9982955078535104,0,0,4
226,Transcription factor regulation in adipogenesis WP3599,0.43942150797684565,1.258953168044077,1.0352323704524191,"['MAPK8', 'IRS1', 'INSR', 'LPIN1']",0.9982955078535104,0,0,4
227,Urea cycle and metabolism of amino groups WP497,0.43942150797684565,1.258953168044077,1.0352323704524191,"['ARG2', 'OAT', 'CKB', 'ALDH18A1']",0.9982955078535104,0,0,4
228,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.439619368138953,1.0389445862194677,0.8538524512345813,"['ITGB1', 'PFKFB4', 'PRKAA1', 'PHLPP1', 'CHRM1', 'CAB39L', 'IRS1', 'LAMA4', 'PIK3R4', 'THBS4', 'PIK3C2B', 'THBS3', 'RPTOR', 'GYS2', 'PPP2CA', 'GYS1', 'PPP2R1B', 'FGF9', 'PPP2R1A', 'AKT2', 'PDGFD', 'ITGB8', 'NOS1', 'EIF4E', 'JAK1', 'MAPK3', 'PDGFRA', 'MAP2K1', 'HSP90AA1', 'PDPK1', 'BAD', 'INSR', 'RPS6', 'VEGFD', 'PPP2R5D', 'PPP2R5C', 'GNG13', 'CREB3', 'EFNA3', 'PPP2R2B', 'AKT1S1', 'KRAS', 'RAF1', 'FGFR2']",0.9982955078535104,0,0,44
229,Phosphodiesterases in neuronal function WP4222,0.44356227271009824,1.1109110550954266,0.9030785656224007,"['GRIA1', 'GUCY1A2', 'GUCY1A1', 'GRIN2A', 'PDE1C', 'PDE1A', 'NOS1', 'PDE7B', 'PDE8A', 'ADCY5']",0.9982955078535104,0,0,10
230,Bladder cancer WP2828,0.443765614668073,1.1495151704723179,0.9339336594588601,"['RB1', 'MAP2K1', 'RPS6KA5', 'CDKN2A', 'DAPK2', 'KRAS', 'RAF1']",0.9982955078535104,0,0,7
231,Bile acids synthesis and enterohepatic circulation  WP4389,0.44899536926164535,1.5106642728904847,1.2096533958307054,"['LDLR', 'MAPK3']",0.9982955078535104,0,0,2
232,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.44899536926164535,1.5106642728904847,1.2096533958307054,"['DDX1', 'ATM']",0.9982955078535104,0,0,2
233,HIF1A and PPARG regulation of glycolysis WP2456,0.44899536926164535,1.5106642728904847,1.2096533958307054,"['LDHA', 'GAPDH']",0.9982955078535104,0,0,2
234,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.44899536926164535,1.5106642728904847,1.2096533958307054,"['ITGB1', 'ZEB2']",0.9982955078535104,0,0,2
235,NAD Biosynthesis II (from tryptophan) WP2485,0.44899536926164535,1.5106642728904847,1.2096533958307054,"['TDO2', 'NADSYN1']",0.9982955078535104,0,0,2
236,Type III interferon signaling WP2113,0.44899536926164535,1.5106642728904847,1.2096533958307054,"['IFNLR1', 'JAK1']",0.9982955078535104,0,0,2
237,DNA IR-double strand breaks and cellular response via ATM WP3959,0.4529693923181745,1.0933471105718187,0.8658551671182516,"['LATS1', 'RAD52', 'UPF1', 'CDK5', 'CDKN2A', 'H2AFX', 'ACTL6A', 'ABL1', 'ATM', 'TERF2', 'RAD9A']",0.9982955078535104,0,0,11
238,Cardiac Progenitor Differentiation WP2406,0.45697835388425034,1.1802435298346514,0.9242714336725003,"['PDGFRA', 'LIN28B', 'ROR2', 'THY1', 'MAPK14']",0.9982955078535104,0,0,5
239,Glycerolipids and Glycerophospholipids WP4722,0.45697835388425034,1.1802435298346514,0.9242714336725003,"['PCYT1A', 'PCYT2', 'GPAM', 'CHPT1', 'AGPAT4']",0.9982955078535104,0,0,5
240,Sphingolipid Metabolism (general overview) WP4725,0.45697835388425034,1.1802435298346514,0.9242714336725003,"['UGCG', 'CERS6', 'SGMS1', 'DEGS1', 'SGPP2']",0.9982955078535104,0,0,5
241,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.45697835388425034,1.1802435298346514,0.9242714336725003,"['SERPINF1', 'ITPR1', 'P3H2', 'P3H1', 'LRP6']",0.9982955078535104,0,0,5
242,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4613878351264355,1.0791248391248391,0.8347206514227551,"['ITGB1', 'MAPK9', 'MAPK8', 'CHUK', 'TNIP1', 'BAD', 'RASA1', 'KRAS', 'NOS1', 'MAPK14', 'NCK1', 'MAPK3']",0.9982955078535104,0,0,12
243,Prader-Willi and Angelman Syndrome WP3998,0.4656397426721267,1.0964955061659583,0.838098695628862,"['RB1', 'PCSK1', 'HERC2', 'CDK6', 'CDKN2A', 'FEZ1', 'NIPA1', 'GABRG3', 'GABRD']",0.9982955078535104,0,0,9
244,Endothelin Pathways WP2197,0.4703116266203758,1.133009708737864,0.8546969417349205,"['MAP2K1', 'ATP2A2', 'ECE1', 'RAF1', 'PLCB1', 'GNG13']",0.9982955078535104,0,0,6
245,Wnt Signaling Pathway WP363,0.47443538841300786,1.079067853284634,0.8045851885621876,"['MAPK9', 'GJA1', 'MAPK8', 'CDK6', 'DVL1', 'TCF4', 'AXIN2', 'ROR2', 'MAP3K7', 'LRP6']",0.9982955078535104,0,0,10
246,Airway smooth muscle cell contraction WP4962,0.4747451518660521,1.258860153256705,0.9378220382877771,"['ROCK1', 'GDI1', 'PLCB1']",0.9982955078535104,0,0,3
247,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.4747451518660521,1.258860153256705,0.9378220382877771,"['TRPC1', 'ITPR1', 'PLCB1']",0.9982955078535104,0,0,3
248,Ganglio Sphingolipid Metabolism WP1423,0.4747451518660521,1.258860153256705,0.9378220382877771,"['ST8SIA3', 'B3GALT1', 'ST8SIA5']",0.9982955078535104,0,0,3
249,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.4747451518660521,1.258860153256705,0.9378220382877771,"['PFKFB4', 'LDHA', 'PDHA1']",0.9982955078535104,0,0,3
250,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.4747451518660521,1.258860153256705,0.9378220382877771,"['SMAD2', 'CDH6', 'MAPK3']",0.9982955078535104,0,0,3
251,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.4759820899076256,1.0574972953479986,0.7850596093098441,"['IDI1', 'PRKAA1', 'SEC24A', 'SAR1B', 'YY1', 'ACLY', 'GPAM', 'SCAP', 'PRKACA', 'LPIN1', 'ATF6', 'LDLR', 'SEC23B', 'KPNB1']",0.9982955078535104,0,0,14
252,IL-5 signaling pathway WP127,0.4810837381168995,1.101513788968825,0.805992986019466,"['MAP2K1', 'JUN', 'RPS6', 'KRAS', 'RAF1', 'JAK1', 'MAPK3']",0.9982955078535104,0,0,7
253,Oxidative Damage WP3941,0.4810837381168995,1.101513788968825,0.805992986019466,"['MAPK10', 'C5', 'MAP3K1', 'BAD', 'GADD45A', 'TNK2', 'MAP3K9']",0.9982955078535104,0,0,7
254,Joubert Syndrome WP4656,0.48240885312675935,1.0490820907487575,0.7647423234190902,"['CEP164', 'CEP120', 'CPLANE1', 'NIN', 'ARL13B', 'KIAA0586', 'TMEM237', 'DVL1', 'MYO6', 'ANKS6', 'ATM', 'ZNF423', 'BBS5', 'CEP290', 'PIBF1']",0.9982955078535104,0,0,15
255,Thermogenesis WP4321,0.48747340461453015,1.0346995658222395,0.7434518609040711,"['MAP2K3', 'PRKAA1', 'RPS6', 'ACTL6A', 'ACSL4', 'CPT1C', 'MAPK14', 'SMARCA2', 'ARID1B', 'ACTB', 'ADCY5', 'RPTOR', 'RPS6KA3', 'CREB3', 'RPS6KA6', 'AKT1S1', 'PRKG2', 'KRAS', 'SLC25A20', 'PRKACA']",0.9982955078535104,0,0,20
256,Vitamin B12 metabolism WP1533,0.49021480007787127,1.1620000552806877,0.8284033376979182,"['INSR', 'HBA1', 'SOD2', 'LDLR']",0.9982955078535104,0,0,4
257,Male infertility WP4673,0.49917736260171947,1.0299418890968186,0.7155972495208484,"['PACRG', 'CCNT2', 'INSR', 'HMGA1', 'PEX10', 'SOD2', 'CLU', 'ETV5', 'PUM2', 'ARNTL', 'AR', 'CCNA1', 'ABLIM1', 'EP300', 'ATM', 'NOS1', 'RAG1', 'NFE2L2']",0.9982955078535104,0,0,18
258,Gene regulatory network modelling somitogenesis  WP2854,0.5058496954061656,1.8881909547738693,1.2868317773931506,['EPHA4'],0.9982955078535104,0,0,1
259,Macrophage markers WP4146,0.5058496954061656,1.8881909547738693,1.2868317773931506,['CD83'],0.9982955078535104,0,0,1
260,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.5058496954061656,1.8881909547738693,1.2868317773931506,['AGT'],0.9982955078535104,0,0,1
261,Steroid Biosynthesis WP496,0.5058496954061656,1.8881909547738693,1.2868317773931506,['HSD17B4'],0.9982955078535104,0,0,1
262,Tgif disruption of Shh signaling WP3674,0.5058496954061656,1.8881909547738693,1.2868317773931506,['SMAD2'],0.9982955078535104,0,0,1
263,IL-18 signaling pathway WP4754,0.5070472083253031,1.010554414153162,0.6863192093435596,"['PRKAA1', 'PIGT', 'CD83', 'MEPCE', 'COX17', 'ENO1', 'KLC1', 'CENPB', 'PTMS', 'RPTOR', 'MAPK9', 'ABHD16A', 'GRM7', 'BSG', 'NFKBIZ', 'LONP2', 'TRPM7', 'LRRFIP1', 'RPS11', 'MAP3K7', 'MAPK3', 'SLC12A3', 'JUN', 'TICAM2', 'USP5', 'CHUK', 'BAD', 'ECH1', 'TACR1', 'FOXN3', 'EEF2', 'ARFGAP2', 'LARS2', 'ARL4D', 'CLDN12', 'HDGF', 'APBA2', 'ARF6']",0.9982955078535104,0,0,38
264,Calcium Regulation in the Cardiac Cell WP536,0.5101913091409344,1.015120724424408,0.6831452941105997,"['CHRM3', 'GNAZ', 'RGS17', 'CHRM1', 'CACNA1B', 'ITPR1', 'GNAI3', 'CACNA1A', 'ATP2A2', 'ARRB1', 'ADCY5', 'GJA1', 'RGS2', 'PRKAR2B', 'GRK4', 'PRKAR2A', 'ANXA6', 'PRKACA', 'CAMK2G', 'RGS6', 'YWHAG', 'ATP1B1', 'GNG13', 'STIM2', 'PRKD1']",0.9982955078535104,0,0,25
265,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5111940631555457,1.038481628242075,0.6968273925691053,"['JUN', 'CTBP2', 'SERPINF1', 'CSNK2A2', 'DVL1', 'ROR2', 'SENP2', 'CXXC4', 'WNT2', 'LRP6', 'EZH2']",0.9982955078535104,0,0,11
266,Focal Adhesion WP306,0.5150713587277795,1.0091368049647165,0.6695116389563115,"['SHC4', 'ITGB1', 'ROCK1', 'LAMA4', 'ACTB', 'THBS4', 'THBS3', 'RAP1B', 'PPP1CC', 'MAPK9', 'MAPK8', 'AKT2', 'PDGFD', 'PAK6', 'ITGB8', 'FLNB', 'FYN', 'PAK2', 'MAPK3', 'PDGFRA', 'JUN', 'MAP2K1', 'PDPK1', 'BAD', 'TNK2', 'VEGFD', 'VAV2', 'MAPK10', 'RAF1', 'PPP1R12B', 'VCL']",0.9982955078535104,0,0,31
267,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5221172707699091,1.0227033765921654,0.6646171454610242,"['RB1', 'MAP2K3', 'MAP2K1', 'JUN', 'PDPK1', 'RPS6', 'GNAI3', 'MAPK14', 'RAP1B', 'RAF1', 'PLCB1', 'JAK1', 'MAPK3']",0.9982955078535104,0,0,13
268,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.5239715352854566,1.2587672052663077,0.8135637994940037,"['ZYG11B', 'UBA3']",0.9982955078535104,0,0,2
269,Integrated Cancer Pathway WP1971,0.5240909042244498,1.04170440868087,0.6730349351207943,"['ATF1', 'RB1', 'SMAD2', 'POU2F1', 'BAD', 'ATM', 'JAK1', 'CDC25B']",0.9982955078535104,0,0,8
270,Apoptosis Modulation and Signaling WP1772,0.526974347198222,1.0166301423063053,0.6512567345168282,"['HRK', 'DAXX', 'JUN', 'ENDOG', 'CDKN2A', 'BAD', 'PIDD1', 'MAPK8', 'CAPNS1', 'MADD', 'PRKD1', 'MAP3K14', 'MCL1', 'MAPK3']",0.9982955078535104,0,0,14
271,Corticotropin-releasing hormone signaling pathway WP2355,0.5315129020354296,1.0114216141001855,0.6392465844429411,"['GNAZ', 'HSP90AA1', 'MAP2K1', 'JUND', 'ARRB1', 'ECE1', 'MAPK14', 'RAP1B', 'MAPK9', 'GJA1', 'MAPK8', 'STAR', 'TCF4', 'RAF1', 'MAPK3']",0.9982955078535104,0,0,15
272,Biomarkers for pyrimidine metabolism disorders WP4584,0.5325888077537572,1.1328663793103448,0.7137121858779811,"['RRM2B', 'DPYD', 'CKB']",0.9982955078535104,0,0,3
273,Cori Cycle WP1946,0.5325888077537572,1.1328663793103448,0.7137121858779811,"['LDHA', 'PGAM1', 'GAPDH']",0.9982955078535104,0,0,3
274,IL-9 signaling pathway WP22,0.5325888077537572,1.1328663793103448,0.7137121858779811,"['MAP2K1', 'MAPK3', 'JAK1']",0.9982955078535104,0,0,3
275,Nicotine Activity on Dopaminergic Neurons WP1602,0.5325888077537572,1.1328663793103448,0.7137121858779811,"['CDK5', 'PRKACA', 'KCNK3']",0.9982955078535104,0,0,3
276,Transcription co-factors SKI and SKIL protein partners WP4533,0.5325888077537572,1.1328663793103448,0.7137121858779811,"['LATS1', 'SATB2', 'NF1']",0.9982955078535104,0,0,3
277,Tryptophan catabolism leading to NAD+ production WP4210,0.5325888077537572,1.1328663793103448,0.7137121858779811,"['TDO2', 'NMNAT3', 'NADSYN1']",0.9982955078535104,0,0,3
278,Heart Development WP1591,0.5389796548118564,1.0788973871977825,0.6668421512424236,"['HEY1', 'BHLHE40', 'NFATC3', 'BMPR1A']",0.9982955078535104,0,0,4
279,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5389796548118564,1.0788973871977825,0.6668421512424236,"['UGCG', 'GALNT1', 'B3GALT1', 'SGPP2']",0.9982955078535104,0,0,4
280,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5389796548118564,1.0788973871977825,0.6668421512424236,"['PTGES2', 'AKT2', 'KRAS', 'MAPK3']",0.9982955078535104,0,0,4
281,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5389796548118564,1.0788973871977825,0.6668421512424236,"['ATF1', 'MAP2K1', 'RPS6KA5', 'MAPK3']",0.9982955078535104,0,0,4
282,Vitamin D in inflammatory diseases WP4482,0.5389796548118564,1.0788973871977825,0.6668421512424236,"['MAP2K3', 'MAP3K1', 'CHUK', 'MAPK14']",0.9982955078535104,0,0,4
283,Zinc homeostasis WP3529,0.5389796548118564,1.0788973871977825,0.6668421512424236,"['SLC30A7', 'SLC39A6', 'SLC39A11', 'SLC39A1']",0.9982955078535104,0,0,4
284,Nuclear Receptors Meta-Pathway WP2882,0.5433711105057079,0.9935240357902401,0.6060126508047475,"['SRXN1', 'GSTP1', 'ABHD2', 'AMIGO2', 'KEAP1', 'SLC2A8', 'AKAP13', 'RGS2', 'SCP2', 'FTH1', 'ENC1', 'SLC39A6', 'CYP1B1', 'EP300', 'POLK', 'SLC39A1', 'SLC19A2', 'GSTM4', 'GSTM3', 'CBR1', 'JUN', 'HSP90AA1', 'JUND', 'SLC6A17', 'NCOA6', 'NCOA3', 'SLC2A13', 'SLC39A11', 'AIP', 'ARNT', 'SLC2A9', 'SLC6A6', 'SLC6A9', 'GPAM', 'NAV3', 'CDC42EP3', 'BHLHE40', 'SPRY1', 'FTL', 'NFE2L2']",0.9982955078535104,0,0,40
285,ESC Pluripotency Pathways WP3931,0.5436326480215703,0.9994582881906826,0.6091513762545546,"['ACVR1', 'MAP2K3', 'PDGFRA', 'MAP2K1', 'JUN', 'LIFR', 'SMAD5', 'LRP6', 'FGF5', 'FGF9', 'AKT2', 'DVL1', 'RAF1', 'WNT2', 'MAP2K5', 'FGFR2', 'BMPR1A', 'JAK1']",0.9982955078535104,0,0,18
286,Endometrial cancer WP4155,0.5440228642301085,1.0068948948948948,0.6129613669923497,"['MAP2K1', 'PDPK1', 'BAD', 'GADD45A', 'AKT2', 'KRAS', 'POLK', 'AXIN2', 'CTNNA2', 'RAF1', 'FGFR2', 'MAPK3']",0.9982955078535104,0,0,12
287,Ethanol effects on histone modifications WP3996,0.5443213070553644,1.0489056633916447,0.6379607543780675,"['HDAC4', 'AHCY', 'HDAC8', 'HDAC9', 'HDAC7']",0.9982955078535104,0,0,5
288,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5443213070553644,1.0489056633916447,0.6379607543780675,"['VMP1', 'LATS1', 'RASSF5', 'STK38L', 'MAPK14']",0.9982955078535104,0,0,5
289,Tumor suppressor activity of SMARCB1 WP4204,0.5490207452159146,1.0298126900068647,0.6174953077949252,"['RB1', 'CDK6', 'CDKN2A', 'ACTL6A', 'ARID1B', 'EZH2']",0.9982955078535104,0,0,6
290,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.5532725174536545,1.0165882678472606,0.6017232726103492,"['NTRK2', 'GABRA1', 'SLC12A5', 'ROCK1', 'AP2B1', 'GABRD', 'GABRG3']",0.9982955078535104,0,0,7
291,p38 MAPK Signaling Pathway WP400,0.5532725174536545,1.0165882678472606,0.6017232726103492,"['DAXX', 'RPS6KA5', 'MAP3K1', 'MAP3K9', 'MAPK14', 'MAP3K7', 'TGFBR1']",0.9982955078535104,0,0,7
292,Type 2 papillary renal cell carcinoma WP4241,0.5532725174536545,1.0165882678472606,0.6017232726103492,"['SETD2', 'EGLN3', 'EGLN2', 'CADM2', 'TFEB', 'EP300', 'ARNT']",0.9982955078535104,0,0,7
293,Ciliopathies WP4803,0.5545757261804153,0.9887522910398727,0.5829208065589474,"['IFT172', 'CEP120', 'CEP164', 'PIK3R4', 'LRRC6', 'FLCN', 'ARL13B', 'TBC1D32', 'KIAA0753', 'POC1B', 'ZNF423', 'PIBF1', 'BBS5', 'CEP290', 'DYNC2H1', 'IQCB1', 'CFAP52', 'IFT140', 'DNAAF5', 'IFT80', 'CPLANE1', 'ARL2BP', 'WDR60', 'TMEM237', 'NME7', 'KIAA0586', 'GPR161', 'ALMS1', 'ANKS6', 'WDPCP', 'CCDC65', 'CCNQ', 'SDCCAG8']",0.9982955078535104,0,0,33
294,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5608368312147897,0.9994600431965442,0.5780129985513585,"['SMAD2', 'MAP2K1', 'KRAS', 'MAP3K9', 'SYNE3', 'SYNE1', 'ADCY5', 'MAPK3', 'PLEC']",0.9982955078535104,0,0,9
295,22q11.2 copy number variation syndrome WP4657,0.5622679896022119,0.9874257150791447,0.5685367127316406,"['RTN4R', 'RTL10', 'CBX5', 'OAT', 'TANGO2', 'KLHL22', 'RTN4', 'ARNTL', 'POLR2A', 'THAP7', 'DGCR6L', 'RAF1', 'HIST1H4C', 'TNPO1', 'DEPDC5', 'KPNB1', 'FGFR2']",0.9982955078535104,0,0,17
296,Genotoxicity pathway WP4286,0.5642685653125199,0.9935939957925061,0.5685592856804808,"['ITPKC', 'RRM2B', 'GADD45A', 'EI24', 'SEL1L', 'PCDH8', 'ITPR1', 'CBLB', 'SMAD5', 'PHLDA3']",0.9982955078535104,0,0,10
297,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5642685653125199,0.9935939957925061,0.5685592856804808,"['MAPK9', 'MAPK8', 'JUN', 'SP3', 'KRAS', 'PLCB1', 'MAPK14', 'CAMK2G', 'JAK1', 'MAPK3']",0.9982955078535104,0,0,10
298,B Cell Receptor Signaling Pathway WP23,0.5791399472250763,0.9763584117032393,0.5332978270094821,"['MAP2K1', 'JUN', 'CHUK', 'PDPK1', 'NFATC3', 'GAB2', 'CBL', 'MAPK14', 'VAV2', 'MAPK9', 'MAPK8', 'FYN', 'RAF1', 'MAP3K7', 'NCK1']",0.9982955078535104,0,0,15
299,Myometrial relaxation and contraction pathways WP289,0.5819819730591576,0.9741631933499119,0.5273299340430393,"['ATF1', 'RGS17', 'GUCY1A1', 'JUN', 'ITPR1', 'ATP2A2', 'ARRB1', 'ACTB', 'GNG13', 'ADCY5', 'CREB3', 'GJA1', 'RGS2', 'CALD1', 'PRKAR2B', 'GRK4', 'PRKAR2A', 'PRKD1', 'IGFBP6', 'NOS1', 'PRKACA', 'CAMK2G', 'RGS6', 'YWHAG']",0.9982955078535104,0,0,24
300,TLR4 Signaling and Tolerance WP3851,0.5852453620726368,1.0068750748592645,0.5394072406099616,"['TBK1', 'CHUK', 'TAB2', 'MAP3K7']",0.9982955078535104,0,0,4
301,Trans-sulfuration and one-carbon metabolism WP2525,0.5852453620726368,1.0068750748592645,0.5394072406099616,"['AHCYL2', 'AHCY', 'DNMT3A', 'PSPH']",0.9982955078535104,0,0,4
302,Kennedy pathway from sphingolipids WP3933,0.5866367740014555,1.0297805642633229,0.549232881426486,"['PCYT1A', 'PCYT2', 'CHPT1']",0.9982955078535104,0,0,3
303,SARS coronavirus and innate immunity WP4912,0.5866367740014555,1.0297805642633229,0.549232881426486,"['TBK1', 'DDX58', 'JAK1']",0.9982955078535104,0,0,3
304,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5866367740014555,1.0297805642633229,0.549232881426486,"['TBK1', 'CHUK', 'ITPR1']",0.9982955078535104,0,0,3
305,Phosphoinositides metabolism WP4971,0.5876750122515283,0.9788435917932321,0.5203348356045855,"['PIP4P1', 'PIK3R4', 'PIP4K2C', 'PLCH2', 'PLCB1', 'PLCD4', 'PIK3C2B']",0.9982955078535104,0,0,7
306,Proximal tubule transport WP4917,0.5876750122515283,0.9788435917932321,0.5203348356045855,"['ATP6V1A', 'ATP6V0B', 'SLC16A10', 'ATP1A1', 'ATP1B1', 'ATP6V0C', 'ATP6V1C1']",0.9982955078535104,0,0,7
307,IL-4 signaling pathway WP395,0.5909931286987148,0.9708114779389078,0.5105991591073501,"['CHUK', 'IRS1', 'BAD', 'EP300', 'GAB2', 'CBL', 'MAPK14', 'JAK1', 'MAPK3']",0.9982955078535104,0,0,9
308,15q11.2 copy number variation syndrome WP4940,0.59171853353431,1.0788407283918953,0.5660938459774685,"['NIPA1', 'TUBGCP4']",0.9982955078535104,0,0,2
309,Biotin Metabolism (including IEMs) WP5031,0.59171853353431,1.0788407283918953,0.5660938459774685,"['HLCS', 'MCCC1']",0.9982955078535104,0,0,2
310,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.59171853353431,1.0788407283918953,0.5660938459774685,"['SMURF1', 'BMPR1A']",0.9982955078535104,0,0,2
311,Genes targeted by miRNAs in adipocytes WP1992,0.59171853353431,1.0788407283918953,0.5660938459774685,"['HDAC4', 'GJA1']",0.9982955078535104,0,0,2
312,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.59171853353431,1.0788407283918953,0.5660938459774685,"['JUN', 'MAPK3']",0.9982955078535104,0,0,2
313,Serotonin and anxiety-related events WP3944,0.59171853353431,1.0788407283918953,0.5660938459774685,"['NLGN1', 'PLCD4']",0.9982955078535104,0,0,2
314,Acute viral myocarditis WP4298,0.5946674433959925,0.9657529656189263,0.5019529512600907,"['SGCD', 'ENDOG', 'RASA1', 'ABL1', 'DMD', 'FYN', 'NOS1', 'ACTB', 'JAK1', 'MAPK3', 'EIF4G1']",0.9982955078535104,0,0,11
315,Neural Crest Differentiation WP2064,0.5946674433959925,0.9657529656189263,0.5019529512600907,"['CDH6', 'ITGB1', 'HDAC4', 'CTBP2', 'DVL1', 'TCF4', 'AXIN2', 'HDAC8', 'HDAC9', 'FGFR2', 'HDAC7']",0.9982955078535104,0,0,11
316,Benzene metabolism WP3891,0.6093436518216503,1.2586743240009572,0.6235131270244847,['DHDH'],0.9982955078535104,0,0,1
317,Composition of Lipid Particles WP3601,0.6093436518216503,1.2586743240009572,0.6235131270244847,['LDLR'],0.9982955078535104,0,0,1
318,FTO Obesity Variant Mechanism WP3407,0.6093436518216503,1.2586743240009572,0.6235131270244847,['FTO'],0.9982955078535104,0,0,1
319,Irinotecan pathway WP229,0.6093436518216503,1.2586743240009572,0.6235131270244847,['ABCC1'],0.9982955078535104,0,0,1
320,miR-517 relationship with ARCN1 and USP1 WP3596,0.6093436518216503,1.2586743240009572,0.6235131270244847,['ARCN1'],0.9982955078535104,0,0,1
321,Nucleotide GPCRs WP80,0.6093436518216503,1.2586743240009572,0.6235131270244847,['LTB4R'],0.9982955078535104,0,0,1
322,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.6093436518216503,1.2586743240009572,0.6235131270244847,['CHRM1'],0.9982955078535104,0,0,1
323,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.6093436518216503,1.2586743240009572,0.6235131270244847,['EPHA4'],0.9982955078535104,0,0,1
324,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.62013254506881,0.9437544996400288,0.4509467016193343,"['RPTOR', 'NTRK2', 'PRKAA1', 'GRIN2A', 'DLG4', 'AKT2', 'NF1', 'KRAS', 'MAPK3']",0.9982955078535104,0,0,9
325,Complement system WP2806,0.6207018784340886,0.9437949640287769,0.4500999514608509,"['PRNP', 'C5', 'C1QBP', 'GNAI3', 'SERPING1', 'CD59', 'PRKACA']",0.9982955078535104,0,0,7
326,IL-6 signaling pathway WP364,0.6207018784340886,0.9437949640287769,0.4500999514608509,"['MAP2K1', 'BAD', 'MAP3K7', 'AGT', 'JAK1', 'MAPK3', 'NR2F6']",0.9982955078535104,0,0,7
327,BDNF-TrkB Signaling WP3676,0.6219694623505183,0.9438151743976987,0.4481841164030373,"['NTRK2', 'MAP2K1', 'EEF2K', 'DLG4', 'KRAS', 'GAB2']",0.9982955078535104,0,0,6
328,Neural Crest Cell Migration during Development WP4564,0.6219694623505183,0.9438151743976987,0.4481841164030373,"['TIAM1', 'JUN', 'AKT2', 'PIK3R4', 'PAK6', 'PAK2']",0.9982955078535104,0,0,6
329,1q21.1 copy number variation syndrome WP4905,0.6286818980718537,0.9438555515630614,0.43807156071321307,"['PYGO1', 'PRKAA1', 'GJA1', 'TJP2']",0.9982955078535104,0,0,4
330,Genes controlling nephrogenesis WP4823,0.6286818980718537,0.9438555515630614,0.43807156071321307,"['ITGB1', 'FGFR2', 'NCK1', 'CD2AP']",0.9982955078535104,0,0,4
331,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6286818980718537,0.9438555515630614,0.43807156071321307,"['RB1', 'PRKAA1', 'GOT2', 'HMGA1']",0.9982955078535104,0,0,4
332,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6364896751922722,0.9438757183908046,0.42643085690158167,"['ACLY', 'PDHA1', 'DLD']",0.9982955078535104,0,0,3
333,Cysteine and methionine catabolism WP4504,0.6519757123243585,0.9438958707360862,0.40374954145245834,"['AHCY', 'SUOX']",0.9982955078535104,0,0,2
334,Development and heterogeneity of the ILC family WP3893,0.6519757123243585,0.9438958707360862,0.40374954145245834,"['BCL11B', 'RORA']",0.9982955078535104,0,0,2
335,Dopamine metabolism WP2436,0.6519757123243585,0.9438958707360862,0.40374954145245834,"['PPP2CA', 'PRKACA']",0.9982955078535104,0,0,2
336,Nanoparticle triggered regulated necrosis WP2513,0.6519757123243585,0.9438958707360862,0.40374954145245834,"['MAPK8', 'FTL']",0.9982955078535104,0,0,2
337,Osteoclast Signaling WP12,0.6519757123243585,0.9438958707360862,0.40374954145245834,"['AIMP2', 'MAPK8']",0.9982955078535104,0,0,2
338,Transcriptional cascade regulating adipogenesis WP4211,0.6519757123243585,0.9438958707360862,0.40374954145245834,"['KLF5', 'KLF15']",0.9982955078535104,0,0,2
339,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6522145544254181,0.9111634830066981,0.38941459832975084,"['TBK1', 'DDX58', 'BSG', 'EP300', 'NUP98', 'IFIT2', 'JAK1']",0.9982955078535104,0,0,7
340,Target Of Rapamycin (TOR) Signaling WP1471,0.6557820097965305,0.9059762675296655,0.38225571037988954,"['RPTOR', 'IDI1', 'PRKAA1', 'RRAGA', 'MAPKAP1', 'AKT1S1']",0.9982955078535104,0,0,6
341,Development of ureteric collection system WP5053,0.6610593135867233,0.8988052445996372,0.372026015789374,"['ITGB1', 'GFRA1', 'SPRY1', 'FGFR2', 'ROBO1']",0.9982955078535104,0,0,5
342,Glycerophospholipid Biosynthetic Pathway WP2533,0.6610593135867233,0.8988052445996372,0.372026015789374,"['PCYT2', 'GPAM', 'PTPMT1', 'CHPT1', 'LPIN1']",0.9982955078535104,0,0,5
343,Nuclear receptors WP170,0.6610593135867233,0.8988052445996372,0.372026015789374,"['AR', 'THRB', 'NR2F1', 'RORA', 'NR2F6']",0.9982955078535104,0,0,5
344,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6610593135867233,0.8988052445996372,0.372026015789374,"['RPTOR', 'BAD', 'TFEB', 'KRAS', 'ATG13']",0.9982955078535104,0,0,5
345,Breast cancer pathway WP4262,0.6685130522388646,0.9213918175856328,0.37104389337619315,"['RB1', 'SHC4', 'MAP2K1', 'JUN', 'GADD45A', 'NCOA3', 'CSNK2A2', 'AXIN2', 'LRP6', 'FGF5', 'CDK6', 'FGF9', 'HEY1', 'AKT2', 'DVL1', 'ATM', 'KRAS', 'POLK', 'RAF1', 'WNT2', 'MAPK3']",0.9982955078535104,0,0,21
346,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6690826968309319,0.8882500898311175,0.35694117913712486,"['SMAD2', 'KRAS', 'RAF1', 'TGFBR1']",0.9982955078535104,0,0,4
347,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6690826968309319,0.8882500898311175,0.35694117913712486,"['SESN3', 'ZMAT3', 'EI24', 'ATM']",0.9982955078535104,0,0,4
348,White fat cell differentiation WP4149,0.6690826968309319,0.8882500898311175,0.35694117913712486,"['KLF5', 'RORA', 'ZNF423', 'KLF15']",0.9982955078535104,0,0,4
349,AMP-activated protein kinase (AMPK) signaling WP1403,0.67095937027363,0.9025106502944493,0.3601438920684987,"['GYS2', 'RPTOR', 'GYS1', 'CCNA1', 'PRKAA1', 'EEF2K', 'AKT2', 'INSR', 'CPT1C', 'PLCB1', 'EEF2']",0.9982955078535104,0,0,11
350,p53 transcriptional gene network WP4963,0.6749634312393398,0.8939126975105149,0.3513941900476542,"['PIDD1', 'RRM2B', 'ZMAT3', 'GADD45A', 'ADGRB1', 'POLK', 'ACAD11', 'CPT1C', 'CX3CL1']",0.9982955078535104,0,0,9
351,Energy Metabolism WP1541,0.6780191380545446,0.888089240734077,0.34509350777168085,"['PRKAA1', 'PPP3CB', 'PPP3CC', 'MYBBP1A', 'EP300', 'NRF1', 'MAPK14', 'CAMK2G']",0.9982955078535104,0,0,8
352,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6819669016346983,0.8711870026525199,0.3334678676057796,"['TBK1', 'DDX58', 'JAK1']",0.9982955078535104,0,0,3
353,One-carbon metabolism and related pathways WP3940,0.682110047974175,0.8807074340527578,0.33692719966560125,"['PCYT2', 'PCYT1A', 'DNMT3A', 'CHPT1', 'BCAT1', 'SOD2', 'BCAT2']",0.9982955078535104,0,0,7
354,Osteoblast differentiation WP4787,0.6874594860793114,0.9011025708699376,0.3376903335234941,"['PIK3R4', 'MAPK14', 'SMAD5', 'PIK3C2B', 'LRP6', 'FGF5', 'MAPK10', 'MAPK9', 'MAPK8', 'FGF9', 'HEY1', 'PRKD1', 'WNT2', 'FGFR2', 'BMPR1A', 'MAPK3']",0.9982955078535104,0,0,16
355,Complement Activation WP545,0.6911681054904578,0.9439160086145011,0.3486563386014759,['C5'],0.9982955078535104,0,0,1
356,Metastatic brain tumor WP2249,0.6911681054904578,0.9439160086145011,0.3486563386014759,['CDK6'],0.9982955078535104,0,0,1
357,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6911681054904578,0.9439160086145011,0.3486563386014759,['HEY1'],0.9982955078535104,0,0,1
358,Small Ligand GPCRs WP247,0.6911681054904578,0.9439160086145011,0.3486563386014759,['S1PR3'],0.9982955078535104,0,0,1
359,Somatic sex determination WP4814,0.6911681054904578,0.9439160086145011,0.3486563386014759,['FGF9'],0.9982955078535104,0,0,1
360,The alternative pathway of fetal androgen synthesis WP4524,0.6911681054904578,0.9439160086145011,0.3486563386014759,['STAR'],0.9982955078535104,0,0,1
361,GABA receptor Signaling WP4159,0.6953320990645679,0.8578687667472714,0.3117200910847729,"['GABRA1', 'AP2B1', 'GABRD', 'GABRG3', 'GPHN']",0.9982955078535104,0,0,5
362,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6953320990645679,0.8578687667472714,0.3117200910847729,"['SMAD2', 'NOS1', 'RAF1', 'TGFBR1', 'MCU']",0.9982955078535104,0,0,5
363,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.7049083861720812,0.8389387592260124,0.2933663414146769,"['ROS1', 'FGFR2']",0.9982955078535104,0,0,2
364,FOXA2 pathway WP5066,0.7049083861720812,0.8389387592260124,0.2933663414146769,"['MLXIPL', 'IRS1']",0.9982955078535104,0,0,2
365,GDNF/RET signaling axis WP4830,0.7049083861720812,0.8389387592260124,0.2933663414146769,"['GFRA1', 'SPRY1']",0.9982955078535104,0,0,2
366,GPR40 Pathway WP3958,0.7049083861720812,0.8389387592260124,0.2933663414146769,"['PLCL1', 'PLCB1']",0.9982955078535104,0,0,2
367,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.7049083861720812,0.8389387592260124,0.2933663414146769,"['RB1', 'TULP3']",0.9982955078535104,0,0,2
368,Mammalian disorder of sexual development WP4842,0.7049083861720812,0.8389387592260124,0.2933663414146769,"['FGF9', 'FGFR2']",0.9982955078535104,0,0,2
369,NO metabolism in cystic fibrosis WP4947,0.7049083861720812,0.8389387592260124,0.2933663414146769,"['PRMT3', 'NOS1']",0.9982955078535104,0,0,2
370,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7049083861720812,0.8389387592260124,0.2933663414146769,"['RAD21', 'MAD2L1']",0.9982955078535104,0,0,2
371,Androgen receptor signaling pathway WP138,0.7079817325909346,0.8843175054112554,0.3053875429112118,"['RB1', 'DAXX', 'JUN', 'ROCK1', 'NCOA3', 'RNF6', 'EFCAB6', 'PIAS2', 'ETV5', 'AR', 'ZNF318', 'EP300', 'PAK6', 'STUB1', 'RAD9A']",0.9982955078535104,0,0,15
372,Notch Signaling WP268,0.7175163609821837,0.8387070997642735,0.2784168136773039,"['APH1A', 'NCSTN', 'CTBP2', 'DVL1', 'PSEN1', 'MAML3']",0.9982955078535104,0,0,6
373,Parkinson's disease pathway WP2371,0.7175163609821837,0.8387070997642735,0.2784168136773039,"['UCHL1', 'PINK1', 'LRRK2', 'UBE2L6', 'EPRS', 'MAPK14']",0.9982955078535104,0,0,6
374,Hippo-Yap signaling pathway WP4537,0.7230565926226907,0.8088823891625616,0.26229450079392885,"['LATS1', 'STK38L', 'MAP4K4']",0.9982955078535104,0,0,3
375,Purine metabolism and related disorders WP4224,0.7230565926226907,0.8088823891625616,0.26229450079392885,"['GRM5', 'RRM2B', 'PAICS']",0.9982955078535104,0,0,3
376,Prion disease pathway WP3995,0.7271388821395377,0.8204919826211984,0.26143974804585857,"['PRNP', 'RAD21', 'EP300', 'FYN', 'MAPK3']",0.9982955078535104,0,0,5
377,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7300948425355757,0.8385910199512214,0.2638046607615758,"['PPP1R16B', 'PPP1CC', 'PPP1R3F', 'MAPK8', 'EIF2AK1', 'PPP1R8', 'PPP1R12B', 'ATF6']",0.9982955078535104,0,0,8
378,Retinoblastoma gene in cancer WP2446,0.7316431565245229,0.8604839423721524,0.2688688562571116,"['RB1', 'FAF1', 'RPA2', 'DCK', 'SMARCA2', 'SMC2', 'CDC25B', 'CDK6', 'MCM3', 'ABL1', 'ZNF655', 'SKP2', 'RAF1']",0.9982955078535104,0,0,13
379,Oxidative Stress WP408,0.740456466394083,0.7945987858615277,0.23876774679006857,"['MAPK10', 'MAPK14', 'SOD2', 'NFE2L2']",0.9982955078535104,0,0,4
380,Pre-implantation embryo WP3527,0.740456466394083,0.7945987858615277,0.23876774679006857,"['CELF3', 'HMGA1', 'ATP1A1', 'HNRNPAB']",0.9982955078535104,0,0,4
381,Proteasome Degradation WP183,0.7425013442478222,0.8384747729364223,0.249639595447071,"['UCHL1', 'PSMA3', 'PSMD12', 'PSMB5', 'PSMC6', 'PSMC3', 'PSMD2', 'PSMD3', 'H2AFX', 'PSMB10']",0.9982955078535104,0,0,10
382,Cancer immunotherapy by PD-1 blockade WP4585,0.750940974385654,0.7549730700179533,0.2162455973731089,"['JUN', 'NFATC3']",0.9982955078535104,0,0,2
383,Major receptors targeted by epinephrine and norepinephrine WP4589,0.750940974385654,0.7549730700179533,0.2162455973731089,"['ADRA2C', 'ADCY5']",0.9982955078535104,0,0,2
384,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.750940974385654,0.7549730700179533,0.2162455973731089,"['TCF4', 'DKK3']",0.9982955078535104,0,0,2
385,Serotonin and anxiety WP3947,0.750940974385654,0.7549730700179533,0.2162455973731089,"['GABRA1', 'PLCD4']",0.9982955078535104,0,0,2
386,Non-small cell lung cancer WP4255,0.7543316808460762,0.8383583583583584,0.2363525979282662,"['RB1', 'MAP2K1', 'CDK6', 'CDKN2A', 'BAD', 'GADD45A', 'RASSF5', 'AKT2', 'KRAS', 'POLK', 'RAF1', 'MAPK3']",0.9982955078535104,0,0,12
387,Benzo(a)pyrene metabolism WP696,0.7558589101885855,0.7550610193826274,0.2113419923090048,['CYP1B1'],0.9982955078535104,0,0,1
388,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.7558589101885855,0.7550610193826274,0.2113419923090048,['SMAD5'],0.9982955078535104,0,0,1
389,EDA signaling in hair follicle development WP3930,0.7558589101885855,0.7550610193826274,0.2113419923090048,['SOSTDC1'],0.9982955078535104,0,0,1
390,Fluoroacetic acid toxicity WP4966,0.7558589101885855,0.7550610193826274,0.2113419923090048,['ALDH3A2'],0.9982955078535104,0,0,1
391,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.7558589101885855,0.7550610193826274,0.2113419923090048,['ADH5'],0.9982955078535104,0,0,1
392,Glucuronidation WP698,0.7558589101885855,0.7550610193826274,0.2113419923090048,['PGM3'],0.9982955078535104,0,0,1
393,Nephrogenesis WP5052,0.7558589101885855,0.7550610193826274,0.2113419923090048,['MEIS1'],0.9982955078535104,0,0,1
394,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.7558589101885855,0.7550610193826274,0.2113419923090048,['CHUK'],0.9982955078535104,0,0,1
395,Selective expression of chemokine receptors during T-cell polarization WP4494,0.7558589101885855,0.7550610193826274,0.2113419923090048,['IL12RB2'],0.9982955078535104,0,0,1
396,Serine Metabolism WP4688,0.7558589101885855,0.7550610193826274,0.2113419923090048,['PSPH'],0.9982955078535104,0,0,1
397,Serotonin Transporter Activity WP1455,0.7558589101885855,0.7550610193826274,0.2113419923090048,['NOS1'],0.9982955078535104,0,0,1
398,Tamoxifen metabolism WP691,0.7558589101885855,0.7550610193826274,0.2113419923090048,['CYP1B1'],0.9982955078535104,0,0,1
399,miRNA regulation of prostate cancer signaling pathways WP3981,0.7564742999345272,0.7862299305056314,0.21942633141546716,"['AR', 'MAP2K1', 'BAD', 'KRAS', 'RAF1']",0.9982955078535104,0,0,5
400,Adipogenesis WP236,0.7574487686247715,0.8549506618531889,0.23750476042856872,"['RB1', 'WWTR1', 'IRS1', 'GADD45A', 'HMGA1', 'NR2F1', 'RORA', 'LIFR', 'MIF', 'KLF15', 'AGT', 'BSCL2', 'BMP3', 'KLF5', 'DVL1', 'LMNA', 'LPIN1']",0.9982955078535104,0,0,17
401,Toll-like Receptor Signaling related to MyD88 WP3858,0.7598719333342372,0.7548850574712643,0.20729548951165314,"['TBK1', 'TICAM2', 'CHUK']",0.9982955078535104,0,0,3
402,TYROBP causal network in microglia WP3945,0.7598719333342372,0.7548850574712643,0.20729548951165314,"['RBM47', 'DPYD', 'TGFBR1']",0.9982955078535104,0,0,3
403,Peptide GPCRs WP24,0.7714672489079705,0.7547969816744521,0.19584042439801855,"['OPRD1', 'TACR1', 'ACKR1', 'SSTR3']",0.9982955078535104,0,0,4
404,Photodynamic therapy-induced unfolded protein response WP3613,0.7714672489079705,0.7547969816744521,0.19584042439801855,"['UBE2E1', 'DNAJB9', 'ATF6', 'NFE2L2']",0.9982955078535104,0,0,4
405,Fatty acid beta-oxidation WP143,0.7833752323043633,0.7547088425593098,0.18425723860121646,"['HADHB', 'ACADVL', 'ACSL4', 'SLC25A20', 'DLD']",0.9982955078535104,0,0,5
406,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7833752323043633,0.7547088425593098,0.18425723860121646,"['LDHA', 'PDHA1', 'PKM', 'ARNT', 'MCL1']",0.9982955078535104,0,0,5
407,Omega-3/Omega-6 FA synthesis WP4723,0.7906413080830436,0.6862738697568141,0.16121319897754435,"['ACSL4', 'PLA2G6']",0.9982955078535104,0,0,2
408,Omega-9 FA synthesis WP4724,0.7906413080830436,0.6862738697568141,0.16121319897754435,"['ELOVL6', 'ACSL4']",0.9982955078535104,0,0,2
409,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7926143673822253,0.7076373922413793,0.16446800107282902,"['ITGB1', 'PDGFRA', 'FGFR2']",0.9982955078535104,0,0,3
410,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7926143673822253,0.7076373922413793,0.16446800107282902,"['BAD', 'MAPK14', 'MCL1']",0.9982955078535104,0,0,3
411,Chemokine signaling pathway WP3929,0.7974854348021259,0.8330378747143433,0.18850956354854786,"['SHC4', 'MAP2K1', 'CHUK', 'ROCK1', 'GNAI3', 'ARRB1', 'CX3CL1', 'GNG13', 'VAV2', 'ADCY5', 'TIAM2', 'RAP1B', 'TIAM1', 'GRK4', 'AKT2', 'KRAS', 'RAF1', 'PLCB1', 'MAPK3']",0.9982955078535104,0,0,19
412,Glycosylation and related congenital defects WP4521,0.7994843811747258,0.7187858255051931,0.1608558454760582,"['DPAGT1', 'TUSC3', 'PMM2', 'MGAT2']",0.9982955078535104,0,0,4
413,IL17 signaling pathway WP2112,0.7994843811747258,0.7187858255051931,0.1608558454760582,"['MAP3K7', 'MAP3K14', 'JAK1', 'MAPK3']",0.9982955078535104,0,0,4
414,Tryptophan metabolism WP465,0.7994843811747258,0.7187858255051931,0.1608558454760582,"['ALDH3A2', 'TDO2', 'CYP1B1', 'DHCR24']",0.9982955078535104,0,0,4
415,Cell cycle WP179,0.8029312635727452,0.8218318985467,0.1803807343453383,"['RB1', 'SMAD2', 'GADD45A', 'CDKN2A', 'CDC25B', 'ORC5', 'MAD2L2', 'CCNA1', 'CDK6', 'STAG2', 'RAD21', 'ABL1', 'MCM3', 'EP300', 'ATM', 'SKP2', 'YWHAG']",0.9982955078535104,0,0,17
416,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.8070027467367406,0.6291576932280449,0.13490915612878432,['DHCR24'],0.9982955078535104,0,0,1
417,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.8070027467367406,0.6291576932280449,0.13490915612878432,['TCF4'],0.9982955078535104,0,0,1
418,Disorders of the Krebs cycle WP4236,0.8070027467367406,0.6291576932280449,0.13490915612878432,['PDHX'],0.9982955078535104,0,0,1
419,Estrogen metabolism WP697,0.8070027467367406,0.6291576932280449,0.13490915612878432,['CYP1B1'],0.9982955078535104,0,0,1
420,Glial Cell Differentiation WP2276,0.8070027467367406,0.6291576932280449,0.13490915612878432,['TPPP'],0.9982955078535104,0,0,1
421,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.8070027467367406,0.6291576932280449,0.13490915612878432,['JAK1'],0.9982955078535104,0,0,1
422,Inflammatory Response Pathway WP453,0.8070027467367406,0.6291576932280449,0.13490915612878432,['THBS3'],0.9982955078535104,0,0,1
423,Ketogenesis and Ketolysis WP4742,0.8070027467367406,0.6291576932280449,0.13490915612878432,['SLC25A20'],0.9982955078535104,0,0,1
424,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.8070027467367406,0.6291576932280449,0.13490915612878432,['LDLR'],0.9982955078535104,0,0,1
425,Osteoblast Signaling WP322,0.8070027467367406,0.6291576932280449,0.13490915612878432,['PDGFRA'],0.9982955078535104,0,0,1
426,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.8070027467367406,0.6291576932280449,0.13490915612878432,['JUN'],0.9982955078535104,0,0,1
427,Supression of HMGB1 mediated inflammation by THBD WP4479,0.8070027467367406,0.6291576932280449,0.13490915612878432,['CHUK'],0.9982955078535104,0,0,1
428,Urea cycle and related diseases WP4571,0.8070027467367406,0.6291576932280449,0.13490915612878432,['SLC25A13'],0.9982955078535104,0,0,1
429,Valproic acid pathway WP3871,0.8070027467367406,0.6291576932280449,0.13490915612878432,['HADHB'],0.9982955078535104,0,0,1
430,Notch Signaling Pathway Netpath WP61,0.8161528521843018,0.7544440446203671,0.15326804079412645,"['APH1A', 'SPEN', 'NCSTN', 'HEY1', 'FHL1', 'EP300', 'MAML3', 'PSEN1']",0.9982955078535104,0,0,8
431,Selenium Micronutrient Network WP15,0.8161528521843018,0.7544440446203671,0.15326804079412645,"['PRDX3', 'SELENOS', 'RFK', 'INSR', 'HBA1', 'SELENOT', 'SOD2', 'LDLR']",0.9982955078535104,0,0,8
432,Complement and Coagulation Cascades WP558,0.8215435776731873,0.665948275862069,0.1309056500026194,"['CLTC', 'SERPING1', 'CLU']",0.9982955078535104,0,0,3
433,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8215435776731873,0.665948275862069,0.1309056500026194,"['YY1', 'CHUK', 'EIF4E']",0.9982955078535104,0,0,3
434,SARS-CoV-2 mitochondrial interactions WP5038,0.8215435776731873,0.665948275862069,0.1309056500026194,"['TBK1', 'DDX58', 'PHB2']",0.9982955078535104,0,0,3
435,Differentiation of white and brown adipocyte WP2895,0.8246420024886629,0.6290245362058647,0.12127965642017718,"['ZNF423', 'SMAD5']",0.9982955078535104,0,0,2
436,Eicosanoid Synthesis WP167,0.8246420024886629,0.6290245362058647,0.12127965642017718,"['PTGES2', 'PLA2G6']",0.9982955078535104,0,0,2
437,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8246420024886629,0.6290245362058647,0.12127965642017718,"['EGLN2', 'CHUK']",0.9982955078535104,0,0,2
438,Pyrimidine metabolism and related diseases WP4225,0.8246420024886629,0.6290245362058647,0.12127965642017718,"['RRM2B', 'DPYD']",0.9982955078535104,0,0,2
439,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8246420024886629,0.6290245362058647,0.12127965642017718,"['BCL2L13', 'MCL1']",0.9982955078535104,0,0,2
440,Oxidation by Cytochrome P450 WP43,0.824652533768198,0.6860484108058668,0.13226543592462162,"['CYB5B', 'CYB5R1', 'CYP2U1', 'CYP1B1']",0.9982955078535104,0,0,4
441,Vitamin D-sensitive calcium signaling in depression WP4698,0.8301824083572488,0.6986713528769604,0.13002960896795349,"['GRIN2A', 'GRM5', 'CHRM1', 'ITPR1', 'NFE2L2']",0.9982955078535104,0,0,5
442,Pyrimidine metabolism WP4022,0.8460925108429201,0.7658559390771449,0.12799487964016218,"['PRIM2', 'PNPT1', 'DCK', 'RRM2B', 'POLR2A', 'NME7', 'POLR2C', 'DPYD', 'CMPK1', 'POLR1E', 'CMPK2', 'POLR3G', 'POLR3H']",0.9982955078535104,0,0,13
443,Fatty Acid Biosynthesis WP357,0.8469536749521661,0.6288912835249042,0.10446467762320484,"['ACLY', 'ECH1', 'ACSL4']",0.9982955078535104,0,0,3
444,Type II interferon signaling (IFNG) WP619,0.8469536749521661,0.6288912835249042,0.10446467762320484,"['IRF2', 'IFIT2', 'JAK1']",0.9982955078535104,0,0,3
445,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8471430021023939,0.6561577278195254,0.10884722659399607,"['HSP90AA1', 'CHUK', 'NLRP1', 'AAMP']",0.9982955078535104,0,0,4
446,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.8474356902015707,0.5392267459747718,0.08926377044020836,['WNT2'],0.9982955078535104,0,0,1
447,ATR Signaling WP3875,0.8474356902015707,0.5392267459747718,0.08926377044020836,['RAD9A'],0.9982955078535104,0,0,1
448,Blood Clotting Cascade WP272,0.8474356902015707,0.5392267459747718,0.08926377044020836,['F8A1'],0.9982955078535104,0,0,1
449,Canonical NF-KB pathway WP4562,0.8474356902015707,0.5392267459747718,0.08926377044020836,['CHUK'],0.9982955078535104,0,0,1
450,"Degradation pathway of sphingolipids, including diseases WP4153",0.8474356902015707,0.5392267459747718,0.08926377044020836,['NEU1'],0.9982955078535104,0,0,1
451,Heme Biosynthesis WP561,0.8474356902015707,0.5392267459747718,0.08926377044020836,['UROD'],0.9982955078535104,0,0,1
452,IL1 and megakaryocytes in obesity WP2865,0.8474356902015707,0.5392267459747718,0.08926377044020836,['TIMP2'],0.9982955078535104,0,0,1
453,Iron metabolism in placenta WP2007,0.8474356902015707,0.5392267459747718,0.08926377044020836,['FTH1'],0.9982955078535104,0,0,1
454,Leptin and adiponectin WP3934,0.8474356902015707,0.5392267459747718,0.08926377044020836,['PRKAA1'],0.9982955078535104,0,0,1
455,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.8474356902015707,0.5392267459747718,0.08926377044020836,['AKT2'],0.9982955078535104,0,0,1
456,Trans-sulfuration pathway WP2333,0.8474356902015707,0.5392267459747718,0.08926377044020836,['AHCY'],0.9982955078535104,0,0,1
457,Apoptosis WP254,0.849856828427137,0.7394070339695115,0.12029219372337098,"['HRK', 'MAPK10', 'HELLS', 'JUN', 'MAP3K1', 'CHUK', 'CDKN2A', 'BAD', 'IRF2', 'MCL1']",0.9982955078535104,0,0,10
458,Allograft Rejection WP2328,0.8503013085718322,0.6736546164116257,0.1092428718833862,"['PDGFRA', 'TUBA1B', 'C5', 'LRRK2', 'CSNK2A2']",0.9982955078535104,0,0,5
459,Mitochondrial complex I assembly model OXPHOS system WP4324,0.8504375619723035,0.718381055192858,0.1163808078822271,"['NUBPL', 'NDUFAF7', 'NDUFAF4', 'NDUFS4', 'NDUFAF2', 'NDUFS2', 'NDUFAF3', 'NDUFS1']",0.9982955078535104,0,0,8
460,Glycosaminoglycan degradation WP4815,0.8535884525866713,0.5805827924319845,0.09190980165158827,"['IDS', 'ARSB']",0.9982955078535104,0,0,2
461,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.8535884525866713,0.5805827924319845,0.09190980165158827,"['SETX', 'EZH2']",0.9982955078535104,0,0,2
462,Mitochondrial complex III assembly WP4921,0.8535884525866713,0.5805827924319845,0.09190980165158827,"['UQCC3', 'CYC1']",0.9982955078535104,0,0,2
463,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8535884525866713,0.5805827924319845,0.09190980165158827,"['ABCD2', 'ABCD3']",0.9982955078535104,0,0,2
464,Overview of interferons-mediated signaling pathway WP4558,0.8535884525866713,0.5805827924319845,0.09190980165158827,"['IFNLR1', 'JAK1']",0.9982955078535104,0,0,2
465,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8535884525866713,0.5805827924319845,0.09190980165158827,"['NRF1', 'NFE2L2']",0.9982955078535104,0,0,2
466,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.8535884525866713,0.5805827924319845,0.09190980165158827,"['PRKAA1', 'LDLR']",0.9982955078535104,0,0,2
467,mRNA Processing WP411,0.8596010219719461,0.7971136458478231,0.120592872612561,"['SRPK2', 'RBM39', 'TMED10', 'SF3B3', 'RNGTT', 'SFSWAP', 'DDX1', 'CELF2', 'SRSF1', 'SUPT5H', 'HNRNPAB', 'NUDT21', 'POLR2A', 'PRPF3', 'SNRPG', 'SPOP', 'CD2BP2', 'DHX38', 'SRSF7', 'SRSF10', 'RBM5', 'SRSF9']",0.9999179784590768,0,0,22
468,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8611131303992056,0.7797661299361154,0.11659795296755604,"['MAP2K3', 'SMAD2', 'MAP2K1', 'TUSC3', 'NUBPL', 'EIF5A2', 'MAPK14', 'TGFBR1', 'LRP6', 'ZEB2', 'MAPK8', 'AKT2', 'CLDN12', 'KRAS', 'RAF1', 'WNT2', 'EZH2', 'MAPK3']",0.9999179784590768,0,0,18
469,"GPCRs, Class A Rhodopsin-like WP455",0.8760701068110968,0.7296251089799477,0.09653608575228144,"['GPR27', 'OPRD1', 'GPR39', 'CHRM3', 'RABGAP1', 'CHRM1', 'HTR1E', 'HTR1F', 'GPR161', 'ADRA2C', 'SSTR3', 'LTB4R']",0.9999179784590768,0,0,12
470,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8781057552837364,0.5390612977686586,0.07007163063811978,"['PRXL2B', 'PLA2G6']",0.9999179784590768,0,0,2
471,Pregnane X receptor pathway WP2876,0.8781057552837364,0.5390612977686586,0.07007163063811978,"['HSP90AA1', 'NCOA3']",0.9999179784590768,0,0,2
472,Autosomal recessive Osteopetrosis pathways WP4788,0.8794002488368423,0.47177853553481697,0.06063068420045754,['PLEKHM1'],0.9999179784590768,0,0,1
473,Cancer immunotherapy by CTLA4 blockade WP4582,0.8794002488368423,0.47177853553481697,0.06063068420045754,['PPP2CA'],0.9999179784590768,0,0,1
474,Copper homeostasis WP3286,0.8846100358443213,0.6286244907740235,0.07707462324278481,"['PRNP', 'JUN', 'COX17', 'ADAM10', 'ADAM9']",0.9999179784590768,0,0,5
475,Melatonin metabolism and effects WP3298,0.8848506997121696,0.6035501257635645,0.07383611888235048,"['PER2', 'CYP1B1', 'ECE1', 'ARNTL']",0.9999179784590768,0,0,4
476,Cytosolic DNA-sensing pathway WP4655,0.8862023788240782,0.6465094775774387,0.07810476855991329,"['TBK1', 'CHUK', 'DDX58', 'POLR3G', 'POLR3H', 'ATG5']",0.9999179784590768,0,0,6
477,Hematopoietic Stem Cell Differentiation WP2849,0.8884595364161452,0.5658943965517241,0.06692616510069911,"['THRB', 'HMGN5', 'ZNF835']",0.9999179784590768,0,0,3
478,Constitutive Androstane Receptor Pathway WP2875,0.898778915636701,0.5030760023937761,0.05368736407745859,"['HSP90AA1', 'NCOA6']",0.9999179784590768,0,0,2
479,Mitochondrial Gene Expression WP391,0.898778915636701,0.5030760023937761,0.05368736407745859,"['NRF1', 'HCFC1']",0.9999179784590768,0,0,2
480,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.898778915636701,0.5030760023937761,0.05368736407745859,"['EIF2S3', 'EIF3G']",0.9999179784590768,0,0,2
481,Purinergic signaling WP4900,0.898778915636701,0.5030760023937761,0.05368736407745859,"['GNAZ', 'GNAI3']",0.9999179784590768,0,0,2
482,Triacylglyceride synthesis WP325,0.898778915636701,0.5030760023937761,0.05368736407745859,"['GPAM', 'AGPAT4']",0.9999179784590768,0,0,2
483,DNA IR-damage and cellular response via ATR WP4016,0.9030865195534495,0.6910002401536983,0.07043843391746239,"['RAD52', 'SMARCAL1', 'UPF1', 'HERC2', 'POLN', 'CEP164', 'UIMC1', 'H2AFX', 'RPA2', 'ATM', 'RAD9A']",0.9999179784590768,0,0,11
484,Alanine and aspartate metabolism WP106,0.9046695570716119,0.4193188163037409,0.042009678800591234,['GOT2'],0.9999179784590768,0,0,1
485,Hedgehog Signaling Pathway Netpath WP47,0.9046695570716119,0.4193188163037409,0.042009678800591234,['ARNTL'],0.9999179784590768,0,0,1
486,ID signaling pathway WP53,0.9046695570716119,0.4193188163037409,0.042009678800591234,['RB1'],0.9999179784590768,0,0,1
487,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.9046695570716119,0.4193188163037409,0.042009678800591234,['IDI1'],0.9999179784590768,0,0,1
488,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.9046695570716119,0.4193188163037409,0.042009678800591234,['DDX58'],0.9999179784590768,0,0,1
489,TCA cycle in senescence WP5050,0.9046695570716119,0.4193188163037409,0.042009678800591234,['PDHA1'],0.9999179784590768,0,0,1
490,Modulators of TCR signaling and T cell activation WP5072,0.9116090304913689,0.6114463978541649,0.0565857415829313,"['CHUK', 'PDPK1', 'RASA2', 'ARIH2', 'CBLB', 'MAP3K14']",0.9999179784590768,0,0,6
491,Apoptosis Modulation by HSP70 WP384,0.9161422277722525,0.471588868940754,0.04130347720824904,"['MAPK10', 'MAP3K1']",0.9999179784590768,0,0,2
492,Immune response to tuberculosis WP4197,0.9161422277722525,0.471588868940754,0.04130347720824904,"['IFIT1', 'JAK1']",0.9999179784590768,0,0,2
493,NAD+ biosynthetic pathways WP3645,0.9161422277722525,0.471588868940754,0.04130347720824904,"['TDO2', 'NADSYN1']",0.9999179784590768,0,0,2
494,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9161422277722525,0.471588868940754,0.04130347720824904,"['IDH3G', 'DLD']",0.9999179784590768,0,0,2
495,Nucleotide Excision Repair WP4753,0.9223550448871503,0.5952989269289729,0.048115064538511436,"['CUL4A', 'DDB1', 'RPA2', 'GTF2H1', 'MNAT1', 'CUL4B']",0.9999179784590768,0,0,6
496,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9225451968488952,0.6136857955496068,0.04947468016116172,"['ITGB1', 'SMARCAL1', 'FYN', 'VCL', 'NCK1', 'CD2AP', 'LRP6']",0.9999179784590768,0,0,7
497,"NAD metabolism, sirtuins and aging WP3630",0.9246455913552362,0.3773510409188801,0.02956347649848345,['ROS1'],0.9999179784590768,0,0,1
498,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.9246455913552362,0.3773510409188801,0.02956347649848345,['JAK1'],0.9999179784590768,0,0,1
499,Mitochondrial CIV Assembly WP4922,0.9261719849063201,0.5387300446588984,0.04131808003263681,"['SURF1', 'COX17', 'CMC1', 'COX5A']",0.9999179784590768,0,0,4
500,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.930674857633041,0.4438061041292639,0.0318853838580245,"['RB1', 'CBX5']",0.9999179784590768,0,0,2
501,Striated Muscle Contraction Pathway WP383,0.930674857633041,0.4438061041292639,0.0318853838580245,"['MYBPC1', 'DMD']",0.9999179784590768,0,0,2
502,Alpha 6 Beta 4 signaling pathway WP244,0.9319670645671779,0.4919415292353823,0.03466111953551694,"['IRS1', 'MAPK14', 'MAPK3']",0.9999179784590768,0,0,3
503,The influence of laminopathies on Wnt signaling WP4844,0.9319670645671779,0.4919415292353823,0.03466111953551694,"['ICMT', 'CDK6', 'LMNA']",0.9999179784590768,0,0,3
504,Cell Differentiation - Index expanded WP2023,0.9404368396649146,0.34301377014944856,0.02106474613260908,['EZH2'],0.9999179784590768,0,0,1
505,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.9428004970025655,0.4191103131857171,0.024685840850995847,"['RASA1', 'FYN']",0.9999179784590768,0,0,2
506,DNA Replication WP466,0.9457353211533648,0.5027188884896395,0.028047961906317625,"['ORC5', 'PRIM2', 'MCM3', 'RPA2']",0.9999179784590768,0,0,4
507,Nephrotic syndrome WP4758,0.9457353211533648,0.5027188884896395,0.028047961906317625,"['SMARCAL1', 'LMNA', 'PMM2', 'CD2AP']",0.9999179784590768,0,0,4
508,PPAR signaling pathway WP3942,0.9500748986973555,0.5235541976196182,0.026813543816165814,"['SCP2', 'PDPK1', 'ACSL4', 'SORBS1', 'CPT1C']",0.9999179784590768,0,0,5
509,Fatty acid transporters WP5061,0.9529197227419608,0.3143993778415889,0.015161789029149622,['ACSL4'],0.9999179784590768,0,0,1
510,"GPCRs, Class B Secretin-like WP334",0.9529197227419608,0.3143993778415889,0.015161789029149622,['ADGRL3'],0.9999179784590768,0,0,1
511,miRNA targets in ECM and membrane receptors WP2911,0.9529197227419608,0.3143993778415889,0.015161789029149622,['LAMA4'],0.9999179784590768,0,0,1
512,PPAR-alpha pathway WP2878,0.9529197227419608,0.3143993778415889,0.015161789029149622,['SCP2'],0.9999179784590768,0,0,1
513,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9568966099604539,0.5093555093555093,0.02244216754457887,"['RB1', 'SMAD2', 'ICMT', 'LMNA', 'ACTB']",0.9999179784590768,0,0,5
514,7-oxo-C and 7beta-HC pathways WP5064,0.9612629986074196,0.3771274685816876,0.014899263769539787,"['ACOT9', 'SCP2']",0.9999179784590768,0,0,2
515,Gastric Cancer Network 2 WP2363,0.9612629986074196,0.3771274685816876,0.014899263769539787,"['AHCTF1', 'UBE2T']",0.9999179784590768,0,0,2
516,Unfolded protein response WP4925,0.9612629986074196,0.3771274685816876,0.014899263769539787,"['ATF6', 'NFE2L2']",0.9999179784590768,0,0,2
517,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.962787164593057,0.29018719973493845,0.011004741461102212,['LTB4R'],0.9999179784590768,0,0,1
518,NAD+ metabolism WP3644,0.962787164593057,0.29018719973493845,0.011004741461102212,['NMNAT3'],0.9999179784590768,0,0,1
519,Riboflavin and CoQ disorders WP5037,0.962787164593057,0.29018719973493845,0.011004741461102212,['RFK'],0.9999179784590768,0,0,1
520,Cholesterol Biosynthesis Pathway WP197,0.9705870004212968,0.26943390421495234,0.00804374321294848,['IDI1'],0.9999179784590768,0,0,1
521,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9725615866288176,0.47101905104241554,0.013104634263683723,"['HELLS', 'JUND', 'ABL1', 'PAK2', 'HSPD1']",0.9999179784590768,0,0,5
522,Lung fibrosis WP3624,0.9739260046359904,0.342777868451118,0.009056173742859943,"['RTEL1', 'NFE2L2']",0.9999179784590768,0,0,2
523,Endochondral Ossification with Skeletal Dysplasias WP4808,0.975712810377115,0.4306965761511216,0.010589531348054099,"['HDAC4', 'CHST11', 'PRKACA', 'BMPR1A']",0.9999179784590768,0,0,4
524,Endochondral Ossification WP474,0.975712810377115,0.4306965761511216,0.010589531348054099,"['HDAC4', 'CHST11', 'PRKACA', 'BMPR1A']",0.9999179784590768,0,0,4
525,Microglia Pathogen Phagocytosis Pathway WP3937,0.9767523476749982,0.25144771476429767,0.005914588724558697,['VAV2'],0.9999179784590768,0,0,1
526,Statin inhibition of cholesterol production WP430,0.9767523476749982,0.25144771476429767,0.005914588724558697,['LDLR'],0.9999179784590768,0,0,1
527,Vitamin D Receptor Pathway WP2877,0.9803465497172305,0.529444519438445,0.010509022447637698,"['GADD45A', 'CDKN2A', 'CLEC16A', 'TIMP2', 'SOSTDC1', 'CDKAL1', 'MYO9B', 'STAM', 'ASAP2']",0.9999179784590768,0,0,9
528,Nanomaterial induced apoptosis WP2507,0.9816256210433183,0.23570979899497488,0.0043713053097771005,['ENDOG'],0.9999179784590768,0,0,1
529,Oxysterols derived from cholesterol WP4545,0.9825415917133336,0.3141532016756433,0.0055330558114317805,"['ACOT9', 'SCP2']",0.9999179784590768,0,0,2
530,Cytoplasmic Ribosomal Proteins WP477,0.9839896755029345,0.5446922872743819,0.008791265081467136,"['RPS6KA3', 'RPS6KA6', 'RPL31', 'RPL27A', 'RPLP0', 'RPS6', 'MRPL19', 'RPL23A', 'RPL8', 'RPS11', 'RPS12']",0.9999179784590768,0,0,11
531,Globo Sphingolipid Metabolism WP1424,0.9854775220854992,0.22182340272792533,0.0032450459715589056,['ST6GALNAC5'],0.9999179784590768,0,0,1
532,Nucleotide metabolism WP404,0.9854775220854992,0.22182340272792533,0.0032450459715589056,['RRM2B'],0.9999179784590768,0,0,1
533,Ovarian infertility WP34,0.9854775220854992,0.22182340272792533,0.0032450459715589056,['ATM'],0.9999179784590768,0,0,1
534,Prostaglandin Synthesis and Regulation WP98,0.9857392699439012,0.30155834829443445,0.004331400602597448,"['CBR1', 'ANXA6']",0.9999179784590768,0,0,2
535,Oxidative phosphorylation WP623,0.9893514285424215,0.409347357234395,0.004382339041888308,"['ATP6AP1', 'ATP6AP2', 'NDUFS4', 'NDUFS2', 'NDUFS1']",0.9999179784590768,0,0,5
536,Vitamin A and carotenoid metabolism WP716,0.9905146382286781,0.27916749783895206,0.0026606433379180784,"['RETSAT', 'BCO2']",0.9999179784590768,0,0,2
537,Differentiation Pathway WP2848,0.9928302794968601,0.18849605168700645,0.0013563320986688587,['WNT2'],0.9999179784590768,0,0,1
538,DNA Mismatch Repair WP531,0.9943334304506558,0.17950295696167914,0.001020058844399085,['RPA2'],0.9999179784590768,0,0,1
539,DNA Repair Pathways Full Network WP4946,0.9943533165285652,0.5262243058059863,0.0029798431455152472,"['MPG', 'H2AFX', 'RPA2', 'GTF2H1', 'TERF2', 'RAD54B', 'DDB1', 'CUL4A', 'RAD52', 'ATM', 'POLK', 'MNAT1', 'FAN1', 'CUL4B']",0.9999179784590768,0,0,14
540,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9962792724301357,0.2896772767462423,0.0010798203366604686,"['IDI1', 'DHCR24', 'ACSL4']",0.9999179784590768,0,0,3
541,Fluoropyrimidine Activity WP1601,0.9964602995016664,0.16386279222197947,0.0005810541939648401,['DPYD'],0.9999179784590768,0,0,1
542,Small cell lung cancer WP4658,0.9965993992233066,0.42378198663010813,0.001443569247735841,"['ITGB1', 'RB1', 'CDK6', 'CHUK', 'GADD45A', 'AKT2', 'LAMA4', 'POLK']",0.9999179784590768,0,0,8
543,Base Excision Repair WP4752,0.9991363077788082,0.12988588261504566,0.00011222989948246377,['MPG'],0.9999179784590768,0,0,1
544,Nonalcoholic fatty liver disease WP4396,0.9991861890298879,0.4569278289092021,0.0003720042708336239,"['JUN', 'PRKAA1', 'IRS1', 'INSR', 'COX5A', 'VMP1', 'MLXIPL', 'MAPK9', 'MAPK8', 'AKT2', 'NDUFS4', 'NDUFS2', 'NDUFS1', 'CYC1']",0.9999179784590768,0,0,14
545,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9999179784590768,0.2781307017193389,2.2813644350988666e-05,"['SURF1', 'COX17', 'NDUFS4', 'NDUFS2', 'NDUFS1', 'COX5A']",0.9999179784590768,0,0,6
